<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
	<channel rdf:about="http://www.mdpi.com/rss/section/medicinal_chemistry">
		<title>Molecules: Medicinal Chemistry</title>
		<link>http://www.mdpi.com/section/medicinal_chemistry</link>
		<description></description>
								<items>
			<rdf:Seq>
							<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/17/2/1388/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/17/2/1373/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/17/2/1278/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/17/1/1124/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/17/1/884/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/17/1/873/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/17/1/613/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/17/1/492/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/17/1/480/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/17/1/315/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/17/1/179/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/12/10685/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/12/10592/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/12/10420/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/12/10409/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/12/10314/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/12/9792/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/11/9755/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/11/9739/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/11/9728/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/11/9636/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/11/9368/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/11/9207/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/11/9129/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/10/8654/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/10/8614/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/10/8292/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/10/8273/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/9/8062/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/9/7864/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/9/7662/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/9/7565/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/8/7068/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/8/7058/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/8/6902/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/8/6778/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/8/6322/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/7/5840/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/7/5753/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/7/5333/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/6/5194/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/6/4897/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/6/4764/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/6/4660/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/6/4482/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/6/4339/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/5/4140/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/5/4104/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/5/4020/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/16/5/3985/" />
                    	</rdf:Seq>
		</items>
				<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
	</channel>
	<item rdf:about="http://www.mdpi.com/1420-3049/17/2/1388/">
	<title>Molecules, Vol. 17, Pages 1388-1407: Synthesis, Docking Studies and Biological Evaluation of Benzo[b]thiophen-2-yl-3-(4-arylpiperazin-1-yl)-propan-1-one Derivatives on 5-HT1A Serotonin Receptors</title>
	<link>http://www.mdpi.com/1420-3049/17/2/1388/</link>
	<description>A series of novel benzo[b]thiophen-2-yl-3-(4-arylpiperazin-1-yl)-propan-1-one derivatives 6a–f, 7a–f and their corresponding alcohols 8a–f were synthesized and evaluated for their affinity towards 5-HT1A receptors. The influence of arylpiperazine moiety and benzo[b]thiophene ring substitutions on binding affinity was studied. The most promising analogue, 1-(benzo[b]thiophen-2-yl)-3-(4-(pyridin-2-yl)piperazin-1-yl)propan-1-one (7e) displayed micromolar affinity (Ki = 2.30 μM) toward 5-HT1A sites. Docking studies shed light on the relevant electrostatic interactions which could explain the observed affinity for this compound.</description>
	
	<guid>http://www.mdpi.com/1420-3049/17/2/1388/</guid>
	<pubDate>Fri, 03 Feb 2012 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2012-02-03</prism:publicationDate>
	<prism:volume>17</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>1388</prism:startingPage>
		<prism:endingPage>1407</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Synthesis, Docking Studies and Biological Evaluation of Benzo[b]thiophen-2-yl-3-(4-arylpiperazin-1-yl)-propan-1-one Derivatives on 5-HT1A Serotonin Receptors</dc:title>
	<dc:date>2012-02-03</dc:date>
	<dc:identifier>doi: 10.3390/molecules17021388</dc:identifier>
		<dc:creator>Hernán Pessoa-Mahana</dc:creator>
		<dc:creator>Gonzalo Recabarren-Gajardo</dc:creator>
		<dc:creator>Jenny Fiedler Temer</dc:creator>
		<dc:creator>Gerald Zapata-Torres</dc:creator>
		<dc:creator>C. David Pessoa-Mahana</dc:creator>
		<dc:creator>Claudio Saitz Barría</dc:creator>
		<dc:creator>Ramiro Araya-Maturana</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/17/2/1373/">
	<title>Molecules, Vol. 17, Pages 1373-1387: Design, Synthesis and Anti-fibrosis Activity Study of N1-Substituted Phenylhydroquinolinone Derivatives</title>
	<link>http://www.mdpi.com/1420-3049/17/2/1373/</link>
	<description>Pirfenidone (5-methyl-1-phenyl-2(1H)-pyridone, PFD) is a small-molecule compound acting on multiple targets involved in pathological fibrogenesis and is effective to increase the survival of patients with fibrosis, such as idiopathic pulmonary fibrosis. However, PFD is not active enough, requiring a high daily dose. In this study, to keep the multiple target profiles, N1-substituted phenylhydroquinolinone derivatives, which retain the 1-phenyl-2(1H)-pyridone scaffold were designed and synthesized. The preliminary anti-fibrosis activities for all target compounds were evaluated on a NIH3T3 fibroblast cell line using MTT assay methods. Most compounds showed significant inhibition on NIH3T3 cell proliferation with a IC50 range of 0.09–26 mM, among which 5-hydroxy-1-(4'-bromophenyl)-5,6,7,8-tetrahydroquinolin-2(1H)-one (6j) displayed 13 times higher potency (IC50 = 0.3 mM) than that of AKF-PD (IC50 = 4.2 mM). These results suggest that N1-substituted phenylhydroquinolinone is a promising scaffold which can be applied for further investigation and for developing novel anti-fibrosis agents.</description>
	
	<guid>http://www.mdpi.com/1420-3049/17/2/1373/</guid>
	<pubDate>Thu, 02 Feb 2012 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2012-02-02</prism:publicationDate>
	<prism:volume>17</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>1373</prism:startingPage>
		<prism:endingPage>1387</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Design, Synthesis and Anti-fibrosis Activity Study of N1-Substituted Phenylhydroquinolinone Derivatives</dc:title>
	<dc:date>2012-02-02</dc:date>
	<dc:identifier>doi: 10.3390/molecules17021373</dc:identifier>
		<dc:creator>Ling Wu</dc:creator>
		<dc:creator>Bin Liu</dc:creator>
		<dc:creator>Qianbin Li</dc:creator>
		<dc:creator>Jun Chen</dc:creator>
		<dc:creator>Lijian Tao</dc:creator>
		<dc:creator>Gaoyun Hu</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/17/2/1278/">
	<title>Molecules, Vol. 17, Pages 1278-1291: Synthesis, Characterization and Cytotoxicity of New Rotundic Acid Derivatives</title>
	<link>http://www.mdpi.com/1420-3049/17/2/1278/</link>
	<description>Rotundic acid (RA, 1), a natural compound, exhibits potent tumor cell growth inhibiting properties. To date there are no reports on derivatives of RA. Furthermore, the 28-COOH position of RA might make it unstable and induced serious gastrointestinal side effects when it was applied in vivo. Therefore, in order to explore and make use of this compound, eight new amino acid derivatives of RA at the 28-COOH position were synthesized and evaluated for their cytotoxicities in vitro on three tumor cell lines including A375, HepG2 and NCI-H446. As a result, a few of these new amino acid derivatives showed stronger cytotoxicity. Compound 5a was found to have the best inhibition activity on the three tested human tumor cell lines with IC50 values of less than 10 μM compared with RA treatment. Meanwhile, the cytotoxicity of compound 6b was significantly higher than that of RA on the A375 cell line and almost the same as RA on the HepG2 and NCI-H446 cell lines. Hence, compounds 5a and 6b may serve as potential lead compounds for the development of new anti-tumor drugs.</description>
	
	<guid>http://www.mdpi.com/1420-3049/17/2/1278/</guid>
	<pubDate>Tue, 31 Jan 2012 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2012-01-31</prism:publicationDate>
	<prism:volume>17</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>1278</prism:startingPage>
		<prism:endingPage>1291</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Synthesis, Characterization and Cytotoxicity of New Rotundic Acid Derivatives</dc:title>
	<dc:date>2012-01-31</dc:date>
	<dc:identifier>doi: 10.3390/molecules17021278</dc:identifier>
		<dc:creator>Yu-Fang He</dc:creator>
		<dc:creator>Min-Lun Nan</dc:creator>
		<dc:creator>Jia-Ming Sun</dc:creator>
		<dc:creator>Zhao-Jie Meng</dc:creator>
		<dc:creator>Fa-Gui Yue</dc:creator>
		<dc:creator>Quan-Cheng Zhao</dc:creator>
		<dc:creator>Xiao-Hong Yang</dc:creator>
		<dc:creator>Hui Wang</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/17/1/1124/">
	<title>Molecules, Vol. 17, Pages 1124-1137: New Sorafenib Derivatives: Synthesis, Antiproliferative Activity Against Tumour Cell Lines and Antimetabolic Evaluation</title>
	<link>http://www.mdpi.com/1420-3049/17/1/1124/</link>
	<description>Sorafenib is a relatively new cytostatic drug approved for the treatment of renal cell and hepatocellular carcinoma. In this report we describe the synthesis of sorafenib derivatives 4a–e which differ from sorafenib in their amide part. A 4-step synthetic pathway includes preparation of 4-chloropyridine-2-carbonyl chloride hydrochloride (1), 4-chloro-pyridine-2-carboxamides 2a–e, 4-(4-aminophenoxy)-pyridine-2-carboxamides 3a–e and the target compounds 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-phenoxy]-pyridine-2-carboxamides 4a–e. All compounds were fully chemically characterized and evaluated for their cytostatic activity against a panel of carcinoma, lymphoma and leukemia tumour cell lines. In addition, their antimetabolic potential was investigated as well. The most prominent antiproliferative activity was obtained for compounds 4a–e (IC50 = 1-4.3 μmol·L−1). Their potency was comparable to the potency of sorafenib, or even better. The compounds inhibited DNA, RNA and protein synthesis to a similar extent and did not discriminate between tumour cell lines and primary fibroblasts in terms of their anti-proliferative activity.</description>
	
	<guid>http://www.mdpi.com/1420-3049/17/1/1124/</guid>
	<pubDate>Mon, 23 Jan 2012 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2012-01-23</prism:publicationDate>
	<prism:volume>17</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>1124</prism:startingPage>
		<prism:endingPage>1137</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>New Sorafenib Derivatives: Synthesis, Antiproliferative Activity Against Tumour Cell Lines and Antimetabolic Evaluation</dc:title>
	<dc:date>2012-01-23</dc:date>
	<dc:identifier>doi: 10.3390/molecules17011124</dc:identifier>
		<dc:creator>Željka Babić</dc:creator>
		<dc:creator>Maja Crkvenčić</dc:creator>
		<dc:creator>Zrinka Rajić</dc:creator>
		<dc:creator>Ana-Matea Mikecin</dc:creator>
		<dc:creator>Marijeta Kralj</dc:creator>
		<dc:creator>Jan Balzarini</dc:creator>
		<dc:creator>Mariya Petrova</dc:creator>
		<dc:creator>Jos Vanderleyden</dc:creator>
		<dc:creator>Branka Zorc</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/17/1/884/">
	<title>Molecules, Vol. 17, Pages 884-896: Design, Synthesis and Antifibrotic Activities of Carbohydrate- Modified 1-(Substituted aryl)-5-trifluoromethyl-2(1H) Pyridones</title>
	<link>http://www.mdpi.com/1420-3049/17/1/884/</link>
	<description>Pirfenidone, a pyridone compound, is an effective and novel antifibrotic agent. In this article, we describe the design, synthesis and activity evaluation of novel antifibrotic agents, 1-(substituted aryl)-5-trifluoromethyl-2(1H) pyridones modified with carbohydrate. Most of the title compounds exhibited comparable or better inhibitory activity than fluorofenidone. Notably, compound 19a demonstrated the highest cell-based inhibitory activity against NIH 3T3 (IC50 = 0.17 mM).</description>
	
	<guid>http://www.mdpi.com/1420-3049/17/1/884/</guid>
	<pubDate>Tue, 17 Jan 2012 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2012-01-17</prism:publicationDate>
	<prism:volume>17</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>884</prism:startingPage>
		<prism:endingPage>896</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Design, Synthesis and Antifibrotic Activities of Carbohydrate- Modified 1-(Substituted aryl)-5-trifluoromethyl-2(1H) Pyridones</dc:title>
	<dc:date>2012-01-17</dc:date>
	<dc:identifier>doi: 10.3390/molecules17010884</dc:identifier>
		<dc:creator>Qinghua Lou</dc:creator>
		<dc:creator>Xiangbao Meng</dc:creator>
		<dc:creator>Zhiqi Lao</dc:creator>
		<dc:creator>Lingling Xuan</dc:creator>
		<dc:creator>Jinye Bai</dc:creator>
		<dc:creator>Qi Hou</dc:creator>
		<dc:creator>Gaoyun Hu</dc:creator>
		<dc:creator>Renna Luo</dc:creator>
		<dc:creator>Lijian Tao</dc:creator>
		<dc:creator>Zhongjun Li</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/17/1/873/">
	<title>Molecules, Vol. 17, Pages 873-883: Novel Benzothiazole, Benzimidazole and Benzoxazole Derivatives as Potential Antitumor Agents: Synthesis and Preliminary in Vitro Biological Evaluation</title>
	<link>http://www.mdpi.com/1420-3049/17/1/873/</link>
	<description>In a previous hit-to-lead research program targeting anticancer agents, two promising lead compounds, 1a and 1b, were found. However, the poor solubility of 1a and 1b made difficult further in vivo studies. To solve this problem, a lead optimization was conducted through introducing N-methyl-piperazine groups at the 2-position and 6-position. To our delight, the optimized analogue 1d showed comparable antiproliferative activity in vitro with better solubility, compared with 1a. Based on this result, the replacement of the benzothiazole scaffold with benzimidazole and benzoxazole moieties afforded 1f and 1g, whose activities were fundamentally retained. In the preliminary in vitro biological evaluation, the immunofluorescence staining of HCT116 cells indicated that 1d, 1f and 1g led to cytosolic vacuolization which was not induced by 1a at low micromolecular concentrations. These results suggest that these optimized compounds might potentially constitute a novel class of anticancer agents, which merit further studies.</description>
	
	<guid>http://www.mdpi.com/1420-3049/17/1/873/</guid>
	<pubDate>Tue, 17 Jan 2012 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2012-01-17</prism:publicationDate>
	<prism:volume>17</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>873</prism:startingPage>
		<prism:endingPage>883</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Novel Benzothiazole, Benzimidazole and Benzoxazole Derivatives as Potential Antitumor Agents: Synthesis and Preliminary in Vitro Biological Evaluation</dc:title>
	<dc:date>2012-01-17</dc:date>
	<dc:identifier>doi: 10.3390/molecules17010873</dc:identifier>
		<dc:creator>Pu Xiang</dc:creator>
		<dc:creator>Tian Zhou</dc:creator>
		<dc:creator>Liang Wang</dc:creator>
		<dc:creator>Chang-Yan Sun</dc:creator>
		<dc:creator>Jing Hu</dc:creator>
		<dc:creator>Ying-Lan Zhao</dc:creator>
		<dc:creator>Li Yang</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/17/1/613/">
	<title>Molecules, Vol. 17, Pages 613-644: Investigating the Spectrum of Biological Activity of Substituted Quinoline-2-Carboxamides and Their Isosteres</title>
	<link>http://www.mdpi.com/1420-3049/17/1/613/</link>
	<description>In this study, a series of thirty-five substituted quinoline-2-carboxamides and thirty-three substituted naphthalene-2-carboxamides were prepared and characterized. They were tested for their activity related to the inhibition of photosynthetic electron transport (PET) in spinach (Spinacia oleracea L.) chloroplasts. Primary in vitro screening of the synthesized compounds was also performed against four mycobacterial species. N-Cycloheptylquinoline-2-carboxamide, N-cyclohexylquinoline-2-carboxamide and N-(2-phenylethyl)quinoline-2-carboxamide showed higher activity against M. tuberculosis than the standards isoniazid or pyrazinamide and 2-(pyrrolidin-1-ylcarbonyl)quinoline and 1-(2-naphthoyl)pyrrolidine expressed higher activity against M. kansasii and M. avium paratuberculosis than the standards isoniazid or pyrazinamide. The most effective antimycobacterial compounds demonstrated insignificant toxicity against the human monocytic leukemia THP-1 cell line. The PET-inhibiting activity expressed by IC50 value of the most active compound N-benzyl-2-naphthamide was 7.5 μmol/L. For all compounds, the structure-activity relationships are discussed.</description>
	
	<guid>http://www.mdpi.com/1420-3049/17/1/613/</guid>
	<pubDate>Tue, 10 Jan 2012 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2012-01-10</prism:publicationDate>
	<prism:volume>17</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>613</prism:startingPage>
		<prism:endingPage>644</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Investigating the Spectrum of Biological Activity of Substituted Quinoline-2-Carboxamides and Their Isosteres</dc:title>
	<dc:date>2012-01-10</dc:date>
	<dc:identifier>doi: 10.3390/molecules17010613</dc:identifier>
		<dc:creator>Tomas Gonec</dc:creator>
		<dc:creator>Pavel Bobal</dc:creator>
		<dc:creator>Josef Sujan</dc:creator>
		<dc:creator>Matus Pesko</dc:creator>
		<dc:creator>Jiahui Guo</dc:creator>
		<dc:creator>Katarina Kralova</dc:creator>
		<dc:creator>Lenka Pavlacka</dc:creator>
		<dc:creator>Libor Vesely</dc:creator>
		<dc:creator>Eva Kreckova</dc:creator>
		<dc:creator>Jiri Kos</dc:creator>
		<dc:creator>Aidan Coffey</dc:creator>
		<dc:creator>Peter Kollar</dc:creator>
		<dc:creator>Ales Imramovsky</dc:creator>
		<dc:creator>Lukas Placek</dc:creator>
		<dc:creator>Josef Jampilek</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/17/1/492/">
	<title>Molecules, Vol. 17, Pages 492-503: Antimycobacterial Activity of Salicylanilide Benzenesulfonates</title>
	<link>http://www.mdpi.com/1420-3049/17/1/492/</link>
	<description>A series of eighteen novel esters of salicylanilides with benzenesulfonic acid were designed, synthesized and characterized by IR, 1H-NMR and 13C-NMR. They were evaluated in vitro as potential antimycobacterial agents towards Mycobacterium tuberculosis, Mycobacterium avium and two strains of Mycobacterium kansasii. In general, the minimum inhibitory concentrations range from 1 to 500 µmol/L. The most active compound against M. tuberculosis was 4-chloro-2-(4-(trifluoromethyl)phenylcarbamoyl)-phenyl benzenesulfonate, with MIC of 1 µmol/L and towards M. kansasii its isomer 5-chloro-2-(4-(trifluoromethyl)phenylcarbamoyl)phenyl benzenesulfonate (MIC of 2–4 µmol/L). M. avium was the less susceptible strain. However, generally, salicylanilide benzenesulfonates did not surpass the activity of other salicylanilide esters with carboxylic acids.
 </description>
	
	<guid>http://www.mdpi.com/1420-3049/17/1/492/</guid>
	<pubDate>Thu, 05 Jan 2012 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2012-01-05</prism:publicationDate>
	<prism:volume>17</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>492</prism:startingPage>
		<prism:endingPage>503</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Antimycobacterial Activity of Salicylanilide Benzenesulfonates</dc:title>
	<dc:date>2012-01-05</dc:date>
	<dc:identifier>doi: 10.3390/molecules17010492</dc:identifier>
		<dc:creator>Martin Krátký</dc:creator>
		<dc:creator>Jarmila Vinšová</dc:creator>
		<dc:creator>Nabila Guisado Rodriguez</dc:creator>
		<dc:creator>Jiřina Stolaříková</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/17/1/480/">
	<title>Molecules, Vol. 17, Pages 480-491: A PAMPA Assay as Fast Predictive Model of Passive Human Skin Permeability of New Synthesized Corticosteroid C-21 Esters</title>
	<link>http://www.mdpi.com/1420-3049/17/1/480/</link>
	<description>The permeation properties of twenty newly synthesized α-alkoxyalkanoyl and α-aryloxyalkanoyl C-21 esters of standard corticosteroids: Fluocinolone acetonide, dexamethasone, triamcinolone acetonide and hydrocortisone were established using a PAMPA assay (70% silicone oil and 30% isopropyl myristate). The data were compared with parent corticosteroids with addition of mometasone furoate and hydrocortisone acetate. All newly synthesized corticosteroid C-21 esters have effective permeability coefficients higher then -6, mostly followed with high values of retention factors and low permeation. The examined compounds were grouped through relationship between obtained retention factors and permeation parameters (groups I–III). The classification confirmed group I (membrane retentions as well as permeation lower then 30%) for all corticosteroid standards except mometasone furoate, a potent topical corticosteroid which, with high membrane retention (81%) and low permeation (7.7%) fits into group III. The largest number of new synthesized corticosteroids C-21 esters, among them all fluocinolone acetonide C-21 esters, have high membrane retentions (32.4%–86.5%) and low permeations (1.3%–27.1%), fitting in group III. The classification was related to previously obtained anti-inflammatory activity data for the fluocinolone acetonide C-21 esters series. According to the PAMPA results the new synthesized esters could be considered as potential new prodrugs with useful benefit/risk ratio.</description>
	
	<guid>http://www.mdpi.com/1420-3049/17/1/480/</guid>
	<pubDate>Thu, 05 Jan 2012 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2012-01-05</prism:publicationDate>
	<prism:volume>17</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>480</prism:startingPage>
		<prism:endingPage>491</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>A PAMPA Assay as Fast Predictive Model of Passive Human Skin Permeability of New Synthesized Corticosteroid C-21 Esters</dc:title>
	<dc:date>2012-01-05</dc:date>
	<dc:identifier>doi: 10.3390/molecules17010480</dc:identifier>
		<dc:creator>Bojan D. Markovic</dc:creator>
		<dc:creator>Sote M. Vladimirov</dc:creator>
		<dc:creator>Olivera A. Cudina</dc:creator>
		<dc:creator>Jadranka V. Odovic</dc:creator>
		<dc:creator>Katarina D. Karljikovic-Rajic</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/17/1/315/">
	<title>Molecules, Vol. 17, Pages 315-327: Neuroprotective Effects of Exogenous Activin A on Oxygen-Glucose Deprivation in PC12 Cells</title>
	<link>http://www.mdpi.com/1420-3049/17/1/315/</link>
	<description>Ischemic cerebrovascular disease is one of the most common causes of death in the World. Exogenous activin A (ActA) protects neurons against toxicity and plays a central role in regulating the brain’s response to injury. In the present study, we investigated the mechanisms involved in the neuroprotective effects of ActA in a model of hypoxic-ischemic brain disease. We found that ActA could effectively increase the survival rate of PC12 cells and relieve oxygen-glucose deprivation (OGD) damage. To clarify the neuroprotective mechanisms of ActA, the effects of ActA on the ActA/Smad pathway and on the up-regulation of inducible nitric oxide synthase (NOS) and superoxide dismutase (SOD) were investigated using OGD in PC12 cells. The results showed that ActA could increase the expression of activin receptor IIA (ActRIIA), Smad3 and Smad4 and that 50 ng/mL and 100 ng/mL of ActA could reduce NO levels and increase SOD activity by 78.9% and 79.9%, respectively. These results suggested that the neuroprotective effects of ActA in ischemia could be related to the activation of the ActA/Smad signaling pathway and to its anti-oxidant activities.</description>
	
	<guid>http://www.mdpi.com/1420-3049/17/1/315/</guid>
	<pubDate>Fri, 30 Dec 2011 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-12-30</prism:publicationDate>
	<prism:volume>17</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>315</prism:startingPage>
		<prism:endingPage>327</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Neuroprotective Effects of Exogenous Activin A on Oxygen-Glucose Deprivation in PC12 Cells</dc:title>
	<dc:date>2011-12-30</dc:date>
	<dc:identifier>doi: 10.3390/molecules17010315</dc:identifier>
		<dc:creator>Jin-Ting He</dc:creator>
		<dc:creator>Jing Mang</dc:creator>
		<dc:creator>Chun-Li Mei</dc:creator>
		<dc:creator>Le Yang</dc:creator>
		<dc:creator>Jiao-Qi Wang</dc:creator>
		<dc:creator>Ying Xing</dc:creator>
		<dc:creator>Hong Yang</dc:creator>
		<dc:creator>Zhong-Xin Xu</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/17/1/179/">
	<title>Molecules, Vol. 17, Pages 179-190: Synthesis of 1,4-Disubstituted Mono and Bis-triazolocarbo-acyclonucleoside Analogues of 9-(4-Hydroxybutyl)guanine by Cu(I)-Catalyzed Click Azide-Alkyne Cycloaddition</title>
	<link>http://www.mdpi.com/1420-3049/17/1/179/</link>
	<description>A series of novel mono-1,2,3-triazole and bis-1,2,3-triazole acyclonucleoside analogues of 9-(4-hydroxybutyl)guanine was prepared via copper(I)-catalyzed 1,3-dipolar cycloaddition of N-9 propargylpurine, N-1-propargylpyrimidines/as-triazine with the azido-pseudo-sugar 4-azidobutylacetate under solvent-free microwave conditions, followed by treatment with K2CO3/MeOH, or NH3/MeOH. All compounds studied in this work were screened for their antiviral activities [against human rhinovirus (HRV) and hepatitis C virus (HCV)] and antibacterial activities against a series of Gram positive and negative bacteria.</description>
	
	<guid>http://www.mdpi.com/1420-3049/17/1/179/</guid>
	<pubDate>Tue, 27 Dec 2011 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-12-27</prism:publicationDate>
	<prism:volume>17</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>179</prism:startingPage>
		<prism:endingPage>190</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Synthesis of 1,4-Disubstituted Mono and Bis-triazolocarbo-acyclonucleoside Analogues of 9-(4-Hydroxybutyl)guanine by Cu(I)-Catalyzed Click Azide-Alkyne Cycloaddition</dc:title>
	<dc:date>2011-12-27</dc:date>
	<dc:identifier>doi: 10.3390/molecules17010179</dc:identifier>
		<dc:creator>Jamal Krim</dc:creator>
		<dc:creator>Moha Taourirte</dc:creator>
		<dc:creator>Joachim W. Engels</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/12/10685/">
	<title>Molecules, Vol. 16, Pages 10685-10694: Novel Pyrazolo[3,4-d]pyrimidine Derivatives as Potential Antitumor Agents: Exploratory Synthesis, Preliminary Structure-Activity Relationships, and in Vitro Biological Evaluation</title>
	<link>http://www.mdpi.com/1420-3049/16/12/10685/</link>
	<description>In a cell-based screen of novel anticancer agents, the hit compound 1a which bears a pyrazolo[3,4-d]pyrimidine scaffold exhibited high inhibitory activity against a panel of four different types of tumor cell lines. In particular, the IC50 for A549 cells was 2.24 µM, compared with an IC50 of 9.20 µM for doxorubicin, the positive control. Four synthetic routes of the key intermediate 3 of 1a were explored and 1a was prepared via route D on the gram scale for further research. Two analogs of 1a were synthesized and their preliminary structure-activity relationships were studied. Flow cytometric analysis revealed that compound 1a could significantly induce apoptosis in A549 cells in vitro at low micromolar concentrations. These results suggest that the target compound 1a and its analogs with the pyrazolo[3,4-d]pyrimidine scaffold might potentially constitute a novel class of anticancer agents, which requires further studies.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/12/10685/</guid>
	<pubDate>Tue, 20 Dec 2011 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-12-20</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>12</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>10685</prism:startingPage>
		<prism:endingPage>10694</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Novel Pyrazolo[3,4-d]pyrimidine Derivatives as Potential Antitumor Agents: Exploratory Synthesis, Preliminary Structure-Activity Relationships, and in Vitro Biological Evaluation</dc:title>
	<dc:date>2011-12-20</dc:date>
	<dc:identifier>doi: 10.3390/molecules161210685</dc:identifier>
		<dc:creator>Hai-Yun He</dc:creator>
		<dc:creator>Jin-Ni Zhao</dc:creator>
		<dc:creator>Ruo Jia</dc:creator>
		<dc:creator>Ying-Lan Zhao</dc:creator>
		<dc:creator>Sheng-Yong Yang</dc:creator>
		<dc:creator>Luo-Ting Yu</dc:creator>
		<dc:creator>Li Yang</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/12/10592/">
	<title>Molecules, Vol. 16, Pages 10592-10603: Global Chemical Composition and Antioxidant and Anti-Tuberculosis Activities of Various Extracts of Globularia alypum L. (Globulariaceae) Leaves</title>
	<link>http://www.mdpi.com/1420-3049/16/12/10592/</link>
	<description>In this work, an evaluation of the biological activities of Globularia alypum L. extracts and their global chemical composition was realized. Extracts from G. alypum were obtained by two extraction methods. The composition of polyphenols (8.5–139.95 g gallic acid equivalent/Kg of dry mass), tannins (1.39–18.65 g catechin equivalent/Kg of dry mass), anthocyanins (8.17–70.69 mg cyanidin equivalent/Kg of dry mass) and flavonoids (0.31–19.28 g quercetin equivalent/Kg of dry mass) was evaluated. The samples were subjected to a screening for their antioxidant activities using the DPPH· and ABTS·+ assays. For the first time, the anti-tuberculosis activity (H37Rv) for G. alypum was tested against Mycobacterium tuberculosis. The strongest antioxidant activity was obtained for the methanol extract (IC50 = 15.58 ± 0.168 mg/L) and the best anti-tuberculosis activity was obtained for the petroleum ether extract (IC50 = 77 mg/L). We have found a positive correlation between the total phenolics content and the antioxidant activity R2 = 0.88 (DPPH·) and R2 = 0.97 (ABTS·+). We have found also a positive correlation between the flavonoid content and the antioxidant activity R2 = 0.91 (DPPH·) and R2 = 0.91 (ABTS·+).</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/12/10592/</guid>
	<pubDate>Mon, 19 Dec 2011 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-12-19</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>12</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>10592</prism:startingPage>
		<prism:endingPage>10603</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Global Chemical Composition and Antioxidant and Anti-Tuberculosis Activities of Various Extracts of Globularia alypum L. (Globulariaceae) Leaves</dc:title>
	<dc:date>2011-12-19</dc:date>
	<dc:identifier>doi: 10.3390/molecules161210592</dc:identifier>
		<dc:creator>Daycem Khlifi</dc:creator>
		<dc:creator>Moktar Hamdi</dc:creator>
		<dc:creator>Akrem El Hayouni</dc:creator>
		<dc:creator>Sylvie Cazaux</dc:creator>
		<dc:creator>Jean Pierre Souchard</dc:creator>
		<dc:creator>François Couderc</dc:creator>
		<dc:creator>Jalloul Bouajila</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/12/10420/">
	<title>Molecules, Vol. 16, Pages 10420-10432: Synthesis and Evaluation of the Anti-Microbial Activity of New Heterocycles Containing the 1,3,4-Thiadiazole Moiety</title>
	<link>http://www.mdpi.com/1420-3049/16/12/10420/</link>
	<description>A new series of thiadiazole-enaminones 4 were synthesized via reactions of 5-acetyl-1,3,4-thiadiazoles 3 with dimethylformamide-dimethylacetal (DMF-DMA). The simple phenyl substituted thiadiazole-enaminone 4f was used as a synthetic precursor for the preparation of a wide variety of new heterocyclic compounds, including the 5-substituted-1,3,4-thiadiazole derivatives 5, 6, 11, 12 and 13, which were obtained via reactions of 4f with nitrogen nucleophiles. Also, reactions of enaminone 4f with carbon nucleophiles afforded the respective 1,3,4-thiadiazoles 8a–d. In addition, the results of the antimicrobial activities of thiadiazole-enaminones 4 and their precursors 2 and 3 indicate that some members of this series display promising activities against all tested microorganisms.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/12/10420/</guid>
	<pubDate>Thu, 15 Dec 2011 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-12-15</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>12</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>10420</prism:startingPage>
		<prism:endingPage>10432</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Synthesis and Evaluation of the Anti-Microbial Activity of New Heterocycles Containing the 1,3,4-Thiadiazole Moiety</dc:title>
	<dc:date>2011-12-15</dc:date>
	<dc:identifier>doi: 10.3390/molecules161210420</dc:identifier>
		<dc:creator>Thoraya A. Farghaly</dc:creator>
		<dc:creator>Magda A. Abdallah</dc:creator>
		<dc:creator>Zienab A. Muhammad</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/12/10409/">
	<title>Molecules, Vol. 16, Pages 10409-10419: Convenient Synthesis and Biological Evaluation of Modafinil Derivatives: Benzhydrylsulfanyl and Benzhydrylsulfinyl [1,2,3]triazol-4-yl-methyl Esters</title>
	<link>http://www.mdpi.com/1420-3049/16/12/10409/</link>
	<description>Simple synthesis and biological activities of modafinil derivatives are described. The key reactions include condensation of acid and propargyl alcohol, subsequent 1,3-dipolar cycloaddition reaction of alkynes and (3-azido-propyl)cyclohexane or (4-azido-butyl)benzene in the presence of sodium ascorbate and CuSO4·5H2O in excellent yield. They were then evaluated for the suppression of LPS-induced NO generation in vitro. It was found that all compounds showed moderate effects for suppression of LPS-induced NO generation.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/12/10409/</guid>
	<pubDate>Thu, 15 Dec 2011 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-12-15</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>12</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>10409</prism:startingPage>
		<prism:endingPage>10419</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Convenient Synthesis and Biological Evaluation of Modafinil Derivatives: Benzhydrylsulfanyl and Benzhydrylsulfinyl [1,2,3]triazol-4-yl-methyl Esters</dc:title>
	<dc:date>2011-12-15</dc:date>
	<dc:identifier>doi: 10.3390/molecules161210409</dc:identifier>
		<dc:creator>Jae-Chul Jung</dc:creator>
		<dc:creator>Yeonju Lee</dc:creator>
		<dc:creator>Jee-Young Son</dc:creator>
		<dc:creator>Eunyoung Lim</dc:creator>
		<dc:creator>Mankil Jung</dc:creator>
		<dc:creator>Seikwan Oh</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/12/10314/">
	<title>Molecules, Vol. 16, Pages 10314-10323: Antimony(V) and Bismuth(V) Complexes of Lapachol: Synthesis, Crystal Structure and Cytotoxic Activity</title>
	<link>http://www.mdpi.com/1420-3049/16/12/10314/</link>
	<description>Antimony(V) and bismuth(V) complexes of lapachol have been synthesized by the reaction of Ph3SbCl2 or Ph3BiCl2 with lapachol (Lp) and characterized by several physicochemical techniques such as IR, and NMR spectroscopy and X-ray crystallography. The compounds contain six-coordinated antimony and bismuth atoms. The antimony(V) complex is a monomeric derivative, (Lp)(Ph3Sb)OH, and the bismuth(V) complex is a dinuclear compound bridged by an oxygen atom, (Lp)2(Ph3Bi)2O. Both compounds inhibited the growth of a chronic myelogenous leukemia cell line and the complex of Bi(V) was about five times more active than free lapachol. This work provides a rare example of an organo-Bi(V) complex showing significant cytotoxic activity.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/12/10314/</guid>
	<pubDate>Tue, 13 Dec 2011 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-12-13</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>12</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>10314</prism:startingPage>
		<prism:endingPage>10323</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Antimony(V) and Bismuth(V) Complexes of Lapachol: Synthesis, Crystal Structure and Cytotoxic Activity</dc:title>
	<dc:date>2011-12-13</dc:date>
	<dc:identifier>doi: 10.3390/molecules161210314</dc:identifier>
		<dc:creator>Ludmila G. de Oliveira</dc:creator>
		<dc:creator>Meiriane M. Silva</dc:creator>
		<dc:creator>Flávia C. S. de Paula</dc:creator>
		<dc:creator>Elene C. Pereira-Maia</dc:creator>
		<dc:creator>Cláudio L. Donnici</dc:creator>
		<dc:creator>Carlos A. de Simone</dc:creator>
		<dc:creator>Frédéric Frézard</dc:creator>
		<dc:creator>Eufrânio N. da Silva Júnior</dc:creator>
		<dc:creator>Cynthia Demicheli</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/12/9792/">
	<title>Molecules, Vol. 16, Pages 9792-9818: Probing the Interaction of Human Serum Albumin with Norfloxacin in the Presence of High-Frequency Electromagnetic Fields: Fluorescence Spectroscopy and Circular Dichroism Investigations</title>
	<link>http://www.mdpi.com/1420-3049/16/12/9792/</link>
	<description>The present study describes an investigation by fluorescence quenching, circular dichroism and UV-visible spectroscopy of the interaction between norfloxacin (NRF) and human serum albumin (HSA) in the presence of electromagnetic fields (EMFs). The results obtained from this study indicated that NRF had a strong ability to quench HSA at λex = 280 nm. In addition, a slight blue shift occurred, which suggested that the microenvironment of the protein became more hydrophobic after addition of NRF. The interaction between the NRF and HSA, whether in the absence or presence of an EMF, was considered to be a static quenching mechanism. Moreover, synchronous fluorescence demonstrated that the microenvironment around Trp became modified. Data of HSA-NRF in the presence of EMFs between 1 Hz–1 MHz confirmed the results of quenching and blue shifts. Corresponding Stern-Volmer plots were also drawn and the resultant Ksv and kq values were compared. Moreover, the binding parameters, including the number of binding sites, the binding constant and the distance, r, between donor and acceptor, were calculated based on Förster’s non-radiative energy transfer theory. According to far and near UV-CD, the formation of the complex caused changes of the secondary and tertiary structures of HSA. The obtained results are significant for patients who are subjected to high-frequency radiation as this was found to reduce the affinity of NRF to HSA.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/12/9792/</guid>
	<pubDate>Fri, 25 Nov 2011 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-11-25</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>12</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>9792</prism:startingPage>
		<prism:endingPage>9818</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Probing the Interaction of Human Serum Albumin with Norfloxacin in the Presence of High-Frequency Electromagnetic Fields: Fluorescence Spectroscopy and Circular Dichroism Investigations</dc:title>
	<dc:date>2011-11-25</dc:date>
	<dc:identifier>doi: 10.3390/molecules16129792</dc:identifier>
		<dc:creator>Olga Azimi</dc:creator>
		<dc:creator>Zahra Emami</dc:creator>
		<dc:creator>Hanieh Salari</dc:creator>
		<dc:creator>Jamshidkhan Chamani</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/11/9755/">
	<title>Molecules, Vol. 16, Pages 9755-9763: Synthesis of Methacrylate Monomers with Antibacterial Effects Against S. Mutans</title>
	<link>http://www.mdpi.com/1420-3049/16/11/9755/</link>
	<description>A series of polymerizable quaternary ammonium compounds were synthesized with the aim of using them as immobilized antibacterial agents in methacrylate dental composites, and their structures were characterized by FT-IR, 1H-NMR, and 13C-NMR analysis. Their antibacterial activities against the oral bacterium Streptococcus mutans were evaluated in vitro by a Minimum Inhibitory Concentration test, and the results showed that 2-dimethyl-2-hexadecyl-1-methacryloxyethyl ammonium iodide (C16) had the highest antibacterial activity against S. mutans, and 2-dimethyl-2-pentyl-1-methacryloxyethyl ammonium iodide (C5) and 2-dimethyl-2-octyl-1-methacryloxyethyl ammonium iodide (C8) did not show any inhibition.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/11/9755/</guid>
	<pubDate>Wed, 23 Nov 2011 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-11-23</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>11</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>9755</prism:startingPage>
		<prism:endingPage>9763</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Synthesis of Methacrylate Monomers with Antibacterial Effects Against S. Mutans</dc:title>
	<dc:date>2011-11-23</dc:date>
	<dc:identifier>doi: 10.3390/molecules16119755</dc:identifier>
		<dc:creator>Jingwei He</dc:creator>
		<dc:creator>Eva Söderling</dc:creator>
		<dc:creator>Monica Österblad</dc:creator>
		<dc:creator>Pekka K. Vallittu</dc:creator>
		<dc:creator>Lippo V. J. Lassila</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/11/9739/">
	<title>Molecules, Vol. 16, Pages 9739-9754: Diversity Oriented Design of Various Benzophenone Derivatives and Their in Vitro Antifungal and Antibacterial Activities</title>
	<link>http://www.mdpi.com/1420-3049/16/11/9739/</link>
	<description>A series of new substituted benzophenone derivatives was designed, synthesized and screened for their antifungal and antibacterial activities. The bioassays indicated that most of the synthesized compounds showed some antifungal activity against the tested phytopathogenic fungi, but lower antibacterial activities towards the five vibrios isolated from marine sources. The preliminary structure activity relationship (SAR) of the compounds was also discussed.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/11/9739/</guid>
	<pubDate>Wed, 23 Nov 2011 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-11-23</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>11</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>9739</prism:startingPage>
		<prism:endingPage>9754</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Diversity Oriented Design of Various Benzophenone Derivatives and Their in Vitro Antifungal and Antibacterial Activities</dc:title>
	<dc:date>2011-11-23</dc:date>
	<dc:identifier>doi: 10.3390/molecules16119739</dc:identifier>
		<dc:creator>Li Sun</dc:creator>
		<dc:creator>Jie Wu</dc:creator>
		<dc:creator>Min Luo</dc:creator>
		<dc:creator>Xiaoli Wang</dc:creator>
		<dc:creator>Man Pan</dc:creator>
		<dc:creator>Zhaopin Gou</dc:creator>
		<dc:creator>Dequn Sun</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/11/9728/">
	<title>Molecules, Vol. 16, Pages 9728-9738: A Curcumin Derivative, 2,6-Bis(2,5-dimethoxybenzylidene)-cyclohexanone (BDMC33) Attenuates Prostaglandin E2 Synthesis via Selective Suppression of Cyclooxygenase-2 in IFN-g/LPS-Stimulated Macrophages</title>
	<link>http://www.mdpi.com/1420-3049/16/11/9728/</link>
	<description>Our preliminary screening had shown that the curcumin derivative [2,6-bis(2,5-dimethoxybenzylidene)cyclohexanone] or BDMC33 exhibited improved anti-inflammatory activity by inhibiting nitric oxide synthesis in activated macrophage cells. In this study, we further investigated the anti-inflammatory properties of BDMC33 on PGE2 synthesis and cyclooxygenase (COX) expression in IFN-g/LPS-stimulated macrophages. We found that BDMC33 significantly inhibited PGE2 synthesis in a concentration-dependent manner albeit at a low inhibition level with an IC50 value of 47.33 ± 1.00 µM. Interestingly, the PGE2 inhibitory activity of BDMC33 is not attributed to inhibition of the COX enzyme activities, but rather BDMC33 selectively down-regulated the expression of COX-2. In addition, BDMC33 modulates the COX expression by sustaining the constitutively COX-1 expression in IFN-g/LPS-treated macrophage cells. Collectively, the experimental data suggest an immunodulatory action of BDMC33 on PGE2 synthesis and COX expression, making it a possible treatment for inflammatory disorders with minimal gastrointestinal-related side effects.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/11/9728/</guid>
	<pubDate>Wed, 23 Nov 2011 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-11-23</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>11</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>9728</prism:startingPage>
		<prism:endingPage>9738</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>A Curcumin Derivative, 2,6-Bis(2,5-dimethoxybenzylidene)-cyclohexanone (BDMC33) Attenuates Prostaglandin E2 Synthesis via Selective Suppression of Cyclooxygenase-2 in IFN-g/LPS-Stimulated Macrophages</dc:title>
	<dc:date>2011-11-23</dc:date>
	<dc:identifier>doi: 10.3390/molecules16119728</dc:identifier>
		<dc:creator>Ka-Heng Lee</dc:creator>
		<dc:creator>Faridah Abas</dc:creator>
		<dc:creator>Noorjahan Banu Mohamed Alitheen</dc:creator>
		<dc:creator>Khozirah Shaari</dc:creator>
		<dc:creator>Nordin Haji Lajis</dc:creator>
		<dc:creator>Syahida Ahmad</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/11/9636/">
	<title>Molecules, Vol. 16, Pages 9636-9650: A Planar Conformation and the Hydroxyl Groups in the B and C Rings Play a Pivotal Role in the Antioxidant Capacity of Quercetin and Quercetin Derivatives</title>
	<link>http://www.mdpi.com/1420-3049/16/11/9636/</link>
	<description>The polyphenol quercetin (Q) that has a high antioxidant capacity is a lead compound in the design of antioxidants. We investigated the possibility of modifying quercetin while retaining its antioxidant capacity as much as possible. To this end, the antioxidant capacities of Q, rutin, monohydroxyethyl rutinoside (monoHER) and a series of synthesized methylated Q derivatives were determined. The results confirm that the electron donating effect of the hydroxyl groups is essential. It was also found that the relatively planar structure of Q needs to be conserved. This planar conformation enables the distribution of the electron donating effect through the large conjugated π-system over the entire molecule. This is essential for the cooperation between the electron donating groups. Based on the activity of the compounds tested, it was concluded that structural modification at the 5 or 7 position is the most optimal to retain most of the antioxidant capacity of Q. This was confirmed by synthesizing and testing Q5OMe (Q6) and Q7OMe (Q7) that indeed displayed antioxidant capacities closest to Q.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/11/9636/</guid>
	<pubDate>Mon, 21 Nov 2011 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-11-21</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>11</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>9636</prism:startingPage>
		<prism:endingPage>9650</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>A Planar Conformation and the Hydroxyl Groups in the B and C Rings Play a Pivotal Role in the Antioxidant Capacity of Quercetin and Quercetin Derivatives</dc:title>
	<dc:date>2011-11-21</dc:date>
	<dc:identifier>doi: 10.3390/molecules16119636</dc:identifier>
		<dc:creator>Mohamed Moalin</dc:creator>
		<dc:creator>Gino P. F. van Strijdonck</dc:creator>
		<dc:creator>Maud Beckers</dc:creator>
		<dc:creator>Geja J. Hagemen</dc:creator>
		<dc:creator>Paul J. Borm</dc:creator>
		<dc:creator>Aalt Bast</dc:creator>
		<dc:creator>Guido R. M. M. Haenen</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/11/9368/">
	<title>Molecules, Vol. 16, Pages 9368-9385: Synthesis and Biological Evaluation of 3-Substituted-indolin-2-one Derivatives Containing Chloropyrrole Moieties</title>
	<link>http://www.mdpi.com/1420-3049/16/11/9368/</link>
	<description>Eighteen novel 3-substituted-indolin-2-ones containing chloropyrroles were synthesized and their biological activities were evaluated. The presence of a chlorine atom on the pyrrole ring was crucial to reduce cardiotoxicity. The presence of a 2-(ethyl-amino)ethylcarbamoyl group as a substituent at the C-4′ position of the pyrrole enhanced the antitumor activities notably. IC50 values as low as 0.32, 0.67, 1.19 and 1.22 μM were achieved against non-small cell lung cancer (A549), oral epithelial (KB), melanoma (K111) and large cell lung cancer cell lines (NCI-H460), respectively.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/11/9368/</guid>
	<pubDate>Tue, 08 Nov 2011 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-11-08</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>11</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>9368</prism:startingPage>
		<prism:endingPage>9385</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Synthesis and Biological Evaluation of 3-Substituted-indolin-2-one Derivatives Containing Chloropyrrole Moieties</dc:title>
	<dc:date>2011-11-08</dc:date>
	<dc:identifier>doi: 10.3390/molecules16119368</dc:identifier>
		<dc:creator>Yun-Zhou Jin</dc:creator>
		<dc:creator>Da-Xu Fu</dc:creator>
		<dc:creator>Nan Ma</dc:creator>
		<dc:creator>Zhan-Cheng Li</dc:creator>
		<dc:creator>Quan-Hai Liu</dc:creator>
		<dc:creator>Lin Xiao</dc:creator>
		<dc:creator>Rong-Hua Zhang</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/11/9207/">
	<title>Molecules, Vol. 16, Pages 9207-9217: Phenolic Compounds from Allium schoenoprasum, Tragopogon pratensis and Rumex acetosa and Their Antiproliferative Effects</title>
	<link>http://www.mdpi.com/1420-3049/16/11/9207/</link>
	<description>Experimental studies have shown that phenolic compounds have antiproliferative and tumour arresting effects. The aim of this original study was to investigate the content of phenolic compounds (PhC) in flowers of Allium schoenoprasum (chive), Tragopogon pratensis (meadow salsify) and Rumex acetosa (common sorrel) and their effect on proliferation of HaCaT cells. Antiproliferative effects were evaluated in vitro using the following concentrations of phenolic compounds in cultivation medium: 100, 75, 50 and 25 µg/mL. Phenolic composition was also determined by HPLC. The results indicate that even low concentrations of these flowers’ phenolic compounds inhibited cell proliferation significantly and the possible use of the studied herb’s flowers as sources of active phenolic compounds for human nutrition.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/11/9207/</guid>
	<pubDate>Thu, 03 Nov 2011 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-11-03</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>11</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>9207</prism:startingPage>
		<prism:endingPage>9217</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Phenolic Compounds from Allium schoenoprasum, Tragopogon pratensis and Rumex acetosa and Their Antiproliferative Effects</dc:title>
	<dc:date>2011-11-03</dc:date>
	<dc:identifier>doi: 10.3390/molecules16119207</dc:identifier>
		<dc:creator>Zdenka Kucekova</dc:creator>
		<dc:creator>Jiri Mlcek</dc:creator>
		<dc:creator>Petr Humpolicek</dc:creator>
		<dc:creator>Otakar Rop</dc:creator>
		<dc:creator>Pavel Valasek</dc:creator>
		<dc:creator>Petr Saha</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/11/9129/">
	<title>Molecules, Vol. 16, Pages 9129-9141: Synthesis and Antifungal Activity of Novel Sulfone Derivatives Containing 1,3,4-Oxadiazole Moieties</title>
	<link>http://www.mdpi.com/1420-3049/16/11/9129/</link>
	<description>A series of new sulfone compounds containing 1,3,4-oxadiazole moieties were synthesized. The structures of these compounds were confirmed by spectroscopic data (IR, 1H- and 13C-NMR) and elemental analyses. Antifungal tests indicated that all the title compounds exhibited good antifungal activities against eight kinds of plant pathogenic fungi, and some showed superiority over the commercial fungicide hymexazol. Among them, compounds 5d, 5e, 5f, and 5i showed prominent activity against B. cinerea, with determined EC50 values of 5.21 μg/mL, 8.25 µg/mL, 8.03 µg/mL, and 21.00 µg/mL, respectively. The present work demonstrates that sulfone derivatives such as 5d containing a 1,3,4-oxadiazole moiety can be used as possible lead compounds for the development of potential agrochemicals.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/11/9129/</guid>
	<pubDate>Tue, 01 Nov 2011 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-11-01</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>11</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>9129</prism:startingPage>
		<prism:endingPage>9141</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Synthesis and Antifungal Activity of Novel Sulfone Derivatives Containing 1,3,4-Oxadiazole Moieties</dc:title>
	<dc:date>2011-11-01</dc:date>
	<dc:identifier>doi: 10.3390/molecules16119129</dc:identifier>
		<dc:creator>Weiming Xu</dc:creator>
		<dc:creator>Jiang He</dc:creator>
		<dc:creator>Ming He</dc:creator>
		<dc:creator>Feifei Han</dc:creator>
		<dc:creator>Xuehai Chen</dc:creator>
		<dc:creator>Zhaoxi Pan</dc:creator>
		<dc:creator>Jian Wang</dc:creator>
		<dc:creator>Maoguo Tong</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/10/8654/">
	<title>Molecules, Vol. 16, Pages 8654-8669: Mechanistic Studies of the Anti-Ulcerogenic Activity and Acute Toxicity Evaluation of Dichlorido-Copper(II)-4-(2-5-Bromo-benzylideneamino)ethyl) Piperazin-1-ium Phenolate Complex against Ethanol-Induced Gastric Injury in Rats</title>
	<link>http://www.mdpi.com/1420-3049/16/10/8654/</link>
	<description>The compound dichlorido-copper(II)-4-(2-5-bromobenzylideneamino)ethyl) piperazin-1-ium phenolate (CuLBS) was synthesized, characterized and screened for acute toxicity and protective activity against ethanol-induced gastric mucosal injury in rats. Gross microscopic lesions, biochemical and immunological parameters and histochemcial staining of glycogen storage were taken into consideration. Oral administration of CuLBS (30 and 60 mg/Kg) for two weeks dose-dependently flattened gastric mucosa, significantly increased gastric mucus and total acidity, compared with control group (P &lt; 0.01). Serum levels of liver enzymes aspartate (AST) and alanine transaminases (ALT), pro-inflammatory (IL-6 and TNF-α) and anti-inflammatory (IL-10) cytokines in the rats exposed to ethanol induced ulceration have been altered. Administration of CuLBS showed considerable (P &lt; 0.05) protection against ulceration by modulating the acute alterations of cytokines AST, ALT and stomach glycogen. Interestingly, CuLBS did not interfere with the natural release of nitric oxide. CuLBS alone (60 mg/Kg) did not exhibit any ulcerogenic effect as assessed using Adami’s scoring scale. An acute toxicity study showed that rats treated with CuLBS (1,000 and 2,000 mg/Kg) manifested no abnormal signs. These findings therefore, suggested that the gastroprotective activity of CuLBS might contribute in modulating the inflammatory cytokine-mediated oxidative damage to gastric mucosa.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/10/8654/</guid>
	<pubDate>Fri, 14 Oct 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-10-14</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>10</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>8654</prism:startingPage>
		<prism:endingPage>8669</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Mechanistic Studies of the Anti-Ulcerogenic Activity and Acute Toxicity Evaluation of Dichlorido-Copper(II)-4-(2-5-Bromo-benzylideneamino)ethyl) Piperazin-1-ium Phenolate Complex against Ethanol-Induced Gastric Injury in Rats</dc:title>
	<dc:date>2011-10-14</dc:date>
	<dc:identifier>doi: 10.3390/molecules16108654</dc:identifier>
		<dc:creator>Muhammad Saleh Salga</dc:creator>
		<dc:creator>Hapipah Mohd Ali</dc:creator>
		<dc:creator>Mahmood Ameen Abdullah</dc:creator>
		<dc:creator>Siddig Ibrahim Abdelwahab</dc:creator>
		<dc:creator>Pouya Davish Hussain</dc:creator>
		<dc:creator>A. Hamid A. Hadi</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/10/8614/">
	<title>Molecules, Vol. 16, Pages 8614-8628: Synthesis and Pharmacological Activity of Diterpenylnaphthoquinone Derivatives</title>
	<link>http://www.mdpi.com/1420-3049/16/10/8614/</link>
	<description>New diterpenylquinones, combining a diterpene diacid and a naphthoquinone, were prepared from junicedric acid and lapachol. The new derivatives were assessed as gastroprotective agents by the HCl-EtOH-induced gastric lesions model in mice as well as for basal cytotoxicity on the following human cell lines: Normal lung fibroblasts (MRC-5), gastric epithelial adenocarcinoma (AGS), and hepatocellular carcinoma (Hep G2). Several of the new compounds were significantly active as antiulcer agents and showed selective cytotoxicity against AGS cells.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/10/8614/</guid>
	<pubDate>Thu, 13 Oct 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-10-13</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>10</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>8614</prism:startingPage>
		<prism:endingPage>8628</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Synthesis and Pharmacological Activity of Diterpenylnaphthoquinone Derivatives</dc:title>
	<dc:date>2011-10-13</dc:date>
	<dc:identifier>doi: 10.3390/molecules16108614</dc:identifier>
		<dc:creator>Mariano Walter Pertino</dc:creator>
		<dc:creator>Cristina Theoduloz</dc:creator>
		<dc:creator>Jose Antonio Palenzuela</dc:creator>
		<dc:creator>Maria del Mar Afonso</dc:creator>
		<dc:creator>Erdem Yesilada</dc:creator>
		<dc:creator>Francisco Monsalve</dc:creator>
		<dc:creator>Paulo González</dc:creator>
		<dc:creator>Daniel Droguett</dc:creator>
		<dc:creator>Guillermo Schmeda-Hirschmann</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/10/8292/">
	<title>Molecules, Vol. 16, Pages 8292-8304: Antihyperlipidemic Properties of Novel N-(Benzoylphenyl)-5-substituted-1H-indole-2-carboxamides in Triton WR-1339-Induced Hyperlipidemic Rats</title>
	<link>http://www.mdpi.com/1420-3049/16/10/8292/</link>
	<description>In the search for new potential antihyperlipidemic agents, the present study focuses on the synthesis of novel N-(benzoylphenyl)-5-substituted-1H-indole-2-carboxamides (compounds 8-12, 15, 16, 18) and investigating their antihyperlipidemic activity using Triton WR-1339-induced hyperlipidemic rats as an experimental model. Hyperlipidemia was developed by intraperitoneal injection of Triton WR-1339 (250 mg/kg body weight). The tested animals were divided into normal control (NCG), hyperlipidemic (HG), compound 8, 9, 15, 16, 18- and bezafibrate treated groups. At a dose of 15 mg/kg body weight, compounds 9, 16, 18 and bezafibrate (100 mg/kg) significantly (p &lt; 0.0001) reduced elevated plasma triglycerides levels after 12 h compared to the hyperlipidemic control group. However, only the group treated with compounds 9, 16 and 18 showed an obviously significant (p &lt; 0.001) reduction in plasma total cholesterol levels after 12 h compared to the hyperlipidemic control group. Moreover, high density lipoprotein-cholesterol levels were significantly (p &lt; 0.0001) increased in all treated groups after 12 h compared to the hyperlipidemic control group, except for compounds 8 and 15 which revealed inactive. It is therefore reasonable to assume that compounds 9, 16 and 18 may have potential in the treatment of hyperlipidemia.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/10/8292/</guid>
	<pubDate>Thu, 29 Sep 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-09-29</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>10</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>8292</prism:startingPage>
		<prism:endingPage>8304</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Antihyperlipidemic Properties of Novel N-(Benzoylphenyl)-5-substituted-1H-indole-2-carboxamides in Triton WR-1339-Induced Hyperlipidemic Rats</dc:title>
	<dc:date>2011-09-29</dc:date>
	<dc:identifier>doi: 10.3390/molecules16108292</dc:identifier>
		<dc:creator>Yusuf Al-Hiari</dc:creator>
		<dc:creator>Ghassan Shattat</dc:creator>
		<dc:creator>Tariq Al-Qirim</dc:creator>
		<dc:creator>Waseem El-Huneidi</dc:creator>
		<dc:creator>Ghassan Abu Sheikha</dc:creator>
		<dc:creator>Suhair Hikmat</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/10/8273/">
	<title>Molecules, Vol. 16, Pages 8273-8291: Helichrysum gymnocephalum Essential Oil: Chemical Composition and Cytotoxic, Antimalarial and Antioxidant Activities, Attribution of the Activity Origin by Correlations</title>
	<link>http://www.mdpi.com/1420-3049/16/10/8273/</link>
	<description>Helichrysum gymnocephalum essential oil (EO) was prepared by hydrodistillation of its leaves and characterized by GC-MS and quantified by GC-FID. Twenty three compounds were identified. 1,8-Cineole (47.4%), bicyclosesquiphellandrene (5.6%), γ-curcumene (5.6%), α-amorphene (5.1%) and bicyclogermacrene (5%) were the main components. Our results confirmed the important chemical variability of H. gymnocephalum. The essential oil was tested in vitro for cytotoxic (on human breast cancer cells MCF-7), antimalarial (Plasmodium falciparum: FcB1-Columbia strain, chloroquine-resistant) and antioxidant (ABTS and DPPH assays) activities. H. gymnocephalum EO was found to be active against MCF-7 cells, with an IC50 of 16 ± 2 mg/L. The essential oil was active against P. falciparum (IC50 = 25 ± 1 mg/L). However, the essential oil exhibited a poor antioxidant activity in the DPPH (IC50 value &gt; 1,000 mg/L) and ABTS (IC50 value = 1,487.67 ± 47.70 mg/L) assays. We have reviewed the existing results on the anticancer activity of essential oils on MCF-7 cell line and on their antiplasmodial activity against the P. falciparum. The aim was to establish correlations between the identified compounds and their biological activities (antiplasmodial and anticancer). β-Selinene (R² = 0.76), α-terpinolene (R² = 0.88) and aromadendrene (R² = 0.90) presented a higher relationship with the anti-cancer activity. However, only calamenene (R² = 0.70) showed a significant correlation for the antiplasmodial activity.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/10/8273/</guid>
	<pubDate>Thu, 29 Sep 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-09-29</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>10</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>8273</prism:startingPage>
		<prism:endingPage>8291</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Helichrysum gymnocephalum Essential Oil: Chemical Composition and Cytotoxic, Antimalarial and Antioxidant Activities, Attribution of the Activity Origin by Correlations</dc:title>
	<dc:date>2011-09-29</dc:date>
	<dc:identifier>doi: 10.3390/molecules16108273</dc:identifier>
		<dc:creator>Samia Afoulous</dc:creator>
		<dc:creator>Hicham Ferhout</dc:creator>
		<dc:creator>Emmanuel Guy Raoelison</dc:creator>
		<dc:creator>Alexis Valentin</dc:creator>
		<dc:creator>Béatrice Moukarzel</dc:creator>
		<dc:creator>François Couderc</dc:creator>
		<dc:creator>Jalloul Bouajila</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/9/8062/">
	<title>Molecules, Vol. 16, Pages 8062-8075: Effects of St John's Wort (Hypericum perforatum L.) Extracts on Epileptogenesis</title>
	<link>http://www.mdpi.com/1420-3049/16/9/8062/</link>
	<description>The purpose of this study was to investigate the effects of treatment with water, n-butanol and ether extracts of Hypercom perforatum L. on epileptogenesis in rabbits. Animals from the control group received solvent-ethanol, and the kindling model of epilepsy was used. Epileptic focus was induced in Chinchilla rabbits by stimulation of the hippocampus. The following parameters were determined: the minimum current strength necessary to induce after-discharge (AD) – discharges appearing after cessation of stimulation; AD duration; the number of stimulations necessary to induce spontaneous kindling; and the latency time for the development of full kindling. The results obtained indicate that epileptogenesis is influenced by Hypericum perforatum L. extract treatment. Animals treated with an ether extract of Hypericum perforatum L. required significantly weaker minimum current strengths for the development of epileptogenic focus, and displayed longer AD times, while the number of electro-stimulations necessary for full kindling was less. In contrast, animals treated with water and n-butanol extracts required increased electro-stimulations for the development of epileptic discharge, and displayed shortened AD durations versus controls.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/9/8062/</guid>
	<pubDate>Mon, 19 Sep 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-09-19</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>8062</prism:startingPage>
		<prism:endingPage>8075</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Effects of St John's Wort (Hypericum perforatum L.) Extracts on Epileptogenesis</dc:title>
	<dc:date>2011-09-19</dc:date>
	<dc:identifier>doi: 10.3390/molecules16098062</dc:identifier>
		<dc:creator>Vesna Ivetic</dc:creator>
		<dc:creator>Svetlana Trivic</dc:creator>
		<dc:creator>Marija Knezevic Pogancev</dc:creator>
		<dc:creator>Mira Popovic</dc:creator>
		<dc:creator>Janka Zlinská</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/9/7864/">
	<title>Molecules, Vol. 16, Pages 7864-7879: Schiff Bases of Indoline-2,3-dione: Potential Novel Inhibitors of Mycobacterium Tuberculosis (Mtb) DNA Gyrase</title>
	<link>http://www.mdpi.com/1420-3049/16/9/7864/</link>
	<description>In the present study a series of Schiff bases of indoline-2,3-dione were synthesized and investigated for their Mtb gyrase inhibitory activity. Promising inhibitory activity was demonstrated with some of these derivatives, which exhibited IC50 values ranging from 50–157 mM. The orientation and the ligand-receptor interactions of such molecules within the Mtb DNA gyrase A subunit active site were investigated applying a multi-step docking protocol using Molecular Operating Environment (MOE) and Autodock4 docking software. The results revealed the importance of the isatin moiety and the connecting side chain for strong interactions with the enzyme active site. Among the tested compounds the terminal aromatic ring benzofuran showed the best activity. Promising new leads for developing a novel class of Mtb gyrase inhibitors were obtained from Schiff bases of indoline-2,3-dione.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/9/7864/</guid>
	<pubDate>Tue, 13 Sep 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-09-13</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>7864</prism:startingPage>
		<prism:endingPage>7879</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Schiff Bases of Indoline-2,3-dione: Potential Novel Inhibitors of Mycobacterium Tuberculosis (Mtb) DNA Gyrase</dc:title>
	<dc:date>2011-09-13</dc:date>
	<dc:identifier>doi: 10.3390/molecules16097864</dc:identifier>
		<dc:creator>Tarek Aboul-Fadl</dc:creator>
		<dc:creator>Hatem A. Abdel-Aziz</dc:creator>
		<dc:creator>Mohammed K. Abdel-Hamid</dc:creator>
		<dc:creator>Tilal Elsaman</dc:creator>
		<dc:creator>Jane Thanassi</dc:creator>
		<dc:creator>Michael J. Pucci</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/9/7662/">
	<title>Molecules, Vol. 16, Pages 7662-7671: Synthesis of Some Oxadiazole Derivatives as New Anticandidal Agents</title>
	<link>http://www.mdpi.com/1420-3049/16/9/7662/</link>
	<description>In this study, 5-[(pyrimidin-2-ylthio)methyl]-1,3,4-oxadiazole-2(3H)-thione (3) was synthesized via the ring closure reaction of 2-(pyrimidin-2-ylthio)acetohydrazide (2) with carbon disulphide. New oxadiazole derivatives 4a-f were obtained by the nucleophilic substitution reaction of compound 3 with various phenacyl bromides. The chemical structures of the compounds were elucidated by IR, 1H-NMR, 13C-NMR and FAB+-MS spectral data and elemental analyses. The newly synthesized derivatives 4a-f were tested in vitro by using a microbroth dilution method against C. albicans (clinical isolate, Osmangazi University, Faculty of Medicine, Eskişehir, Turkey), C. albicans (ATCC 90028), C. glabrata (clinical isolate, Osmangazi University, Faculty of Medicine, Eskişehir, Turkey), C. tropicalis (NRRL Y-12968), C. krusei (NRRL Y-7179), C. parapsilosis (NRRL Y- 12696), C. albicans (NRRL Y-12983), C. glabrata (clinical isolate, Anadolu University, Faculty of Science, Department of Biology, Eskişehir, Turkey). Among these compounds, compound 4a was found to be the most potent derivative (MIC = 0.007–0.06 versus ketoconazole: 0.001–0.007 mg/mL) against Candida species, except C. tropicalis and C. krusei when compared with the standard antifungal ketoconazole.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/9/7662/</guid>
	<pubDate>Wed, 07 Sep 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-09-07</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>7662</prism:startingPage>
		<prism:endingPage>7671</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Synthesis of Some Oxadiazole Derivatives as New Anticandidal Agents</dc:title>
	<dc:date>2011-09-07</dc:date>
	<dc:identifier>doi: 10.3390/molecules16097662</dc:identifier>
		<dc:creator>Zafer Asim Kaplancikli</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/9/7565/">
	<title>Molecules, Vol. 16, Pages 7565-7582: 1,3-Substituted Imidazolidine-2,4,5-triones: Synthesis and Inhibition of Cholinergic Enzymes</title>
	<link>http://www.mdpi.com/1420-3049/16/9/7565/</link>
	<description>A series of novel and highly active acetylcholinesterase and butyrylcholinesterase inhibitors derived from substituted benzothiazoles containing an imidazolidine-2,4,5-trione moiety were synthesized and characterized. The molecular structure of 1-(2,6-diisopropyl-phenyl)-3-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-imidazolidine-2,4,5-trione (3g) was determined by single-crystal X-ray diffraction. Both optical isomers are present as two independent molecules in the triclinic crystal system. The lipophilicity of the compounds was determined as the partition coefficient log Kow using the traditional shake-flask method. The in vitro inhibitory activity on acetylcholinesterase from electric eel and butyrylcholinesterase isolated from equine serum was determined. The inhibitory activity on acetylcholinesterase was significantly higher than that of the standard drug rivastigmine. The discussed compounds are also promising inhibitors of butyrylcholinesterase, as some of the prepared compounds inhibit butyrylcholinesterase better than the internal standards rivastigmine and galanthamine. The highest inhibitory activity (IC50 = 1.66 μmol/L) corresponds to the compound 1-(4-isopropylphenyl)-3-[(R)-1-(6-fluorobenzo[d]thiazol-2-yl)ethyl]imidazolidine-2,4,5-trione (3d). For all the studied compounds, the relationships between the lipophilicity and the chemical structure as well as their structure-activity relationships are discussed.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/9/7565/</guid>
	<pubDate>Mon, 05 Sep 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-09-05</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>9</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>7565</prism:startingPage>
		<prism:endingPage>7582</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>1,3-Substituted Imidazolidine-2,4,5-triones: Synthesis and Inhibition of Cholinergic Enzymes</dc:title>
	<dc:date>2011-09-05</dc:date>
	<dc:identifier>doi: 10.3390/molecules16097565</dc:identifier>
		<dc:creator>Vladimir Pejchal</dc:creator>
		<dc:creator>Sarka Stepankova</dc:creator>
		<dc:creator>Zdenka Padelkova</dc:creator>
		<dc:creator>Ales Imramovsky</dc:creator>
		<dc:creator>Josef Jampilek</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/8/7068/">
	<title>Molecules, Vol. 16, Pages 7068-7080: Activity and Stability Studies of Verbascoside, a Novel Antioxidant, in Dermo-Cosmetic and Pharmaceutical Topical Formulations</title>
	<link>http://www.mdpi.com/1420-3049/16/8/7068/</link>
	<description>We here report the results of our investigations carried out on verbascoside, a phenylpropanoid glycoside known for its antioxidant, anti-inflammatory and photoprotective actions. Verbascoside was obtained from Buddleia davidii meristematic cells, obtained in turn using a sustainable biotechnology platform which employs an in vitro plant cell culture technology. Verbascoside was first investigated to assess the behaviour of the active ingredient in solution or in finished preparations, in view of its potential topical use, especially in skin protection. Stability studies were performed by HPLC, and a PCL assay was adopted to determine the radical scavenging activity toward superoxide anion. The high hydrophilic character of verbascoside, suggested in a somewhat limited range of possible applications, leading us to explore its derivatization to obtain the semi-synthetic derivative VPP, an acyl derivative of verbascoside, with an improved range of applications due to its lower hydrophilic profile. Alone, VPP revealed increased antioxidant activity, both as an active ingredient and in dermocosmetic preparations. Stability studies showed a greater stability of VPP in lipophilic vehicles, whereas the parent verbascoside proved more stable in an O/W emulsions. Verbascoside was also stable in suppositories, an interesting pharmaceutical form for possible applications in treatment of inflammation of the intestinal mucosa.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/8/7068/</guid>
	<pubDate>Thu, 18 Aug 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-08-18</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>7068</prism:startingPage>
		<prism:endingPage>7080</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Activity and Stability Studies of Verbascoside, a Novel Antioxidant, in Dermo-Cosmetic and Pharmaceutical Topical Formulations</dc:title>
	<dc:date>2011-08-18</dc:date>
	<dc:identifier>doi: 10.3390/molecules16087068</dc:identifier>
		<dc:creator>Silvia Vertuani</dc:creator>
		<dc:creator>Erika Beghelli</dc:creator>
		<dc:creator>Emanuela Scalambra</dc:creator>
		<dc:creator>Gemma Malisardi</dc:creator>
		<dc:creator>Stefano Copetti</dc:creator>
		<dc:creator>Roberto Dal Toso</dc:creator>
		<dc:creator>Anna Baldisserotto</dc:creator>
		<dc:creator>Stefano Manfredini</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/8/7058/">
	<title>Molecules, Vol. 16, Pages 7058-7067: Simple and Rapid Method for the Determination of Uric Acid-Independent Antioxidant Capacity</title>
	<link>http://www.mdpi.com/1420-3049/16/8/7058/</link>
	<description>Determination of the relative contribution of uric acid level increases to the total measured antioxidative activity could be very useful for testing antioxidative products and their effect on human health. The aim of this report is to present a simple spectrophotometric method that combines the measurement of total antioxidative capacity of a sample by ferric reducing/antioxidative power (FRAP) assay, with the uricase-reaction (specific elimination of uric acid), in order to establish and correct for the contribution of uric acid in FRAP values. We measured FRAP values, with (uric acid-independent antioxidant capacity, TAC-UA) and without (total antioxidant capacity, TAC) uricase treatment, and expressed it as μmol/L of uric acid equivalents. In such way, it was possible to determine both total and uric acid-independent antioxidant capacity, plasma uric acid (UA, as the difference between TAC and TAC-UA), and the ratio of the uric acid in total antioxidant capacity (UA/TAC).</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/8/7058/</guid>
	<pubDate>Wed, 17 Aug 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-08-17</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>7058</prism:startingPage>
		<prism:endingPage>7067</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Simple and Rapid Method for the Determination of Uric Acid-Independent Antioxidant Capacity</dc:title>
	<dc:date>2011-08-17</dc:date>
	<dc:identifier>doi: 10.3390/molecules16087058</dc:identifier>
		<dc:creator>Darko Duplancic</dc:creator>
		<dc:creator>Lea Kukoc-Modun</dc:creator>
		<dc:creator>Darko Modun</dc:creator>
		<dc:creator>Njegomir Radic</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/8/6902/">
	<title>Molecules, Vol. 16, Pages 6902-6915: Analgesic and Anti-Inflammatory Activities of Salicylaldehyde 2-Chlorobenzoyl Hydrazone (H2LASSBio-466), Salicylaldehyde 4-Chlorobenzoyl Hydrazone (H2LASSBio-1064) and Their Zinc(II) Complexes</title>
	<link>http://www.mdpi.com/1420-3049/16/8/6902/</link>
	<description>Salicylaldehyde 2-chlorobenzoyl hydrazone (H2LASSBio-466), salicylaldehyde 4-chlorobenzoyl hydrazone (H2LASSBio-1064) and their complexes [Zn(LASSBio-466)H2O]2 (1) and [Zn(HLASSBio-1064)Cl]2 (2) were evaluated in animal models of peripheral and central nociception, and acute inflammation. All studied compounds significantly inhibited acetic acid-induced writhing response. Upon coordination the anti-nociceptive activity was favored in the complex 1. H2LASSBio-466 inhibited only the first phase of the formalin test, while 1 was active in the second phase, like indomethacin, indicating its ability to inhibit nociception associated with the inflammatory response. Hence coordination to zinc(II) altered the pharmacological profile of H2LASSBio-466. H2LASSBio-1064 inhibited both phases but this effect was not improved by coordination. The studied compounds did not increase the latency of response in the hot plate model, indicating their lack of central anti-nociceptive activity. All compounds showed levels of inhibition of zymosan-induced peritonitis comparable or superior to indomethacin, indicating an expressive anti-inflammatory profile.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/8/6902/</guid>
	<pubDate>Mon, 15 Aug 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-08-15</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>6902</prism:startingPage>
		<prism:endingPage>6915</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Analgesic and Anti-Inflammatory Activities of Salicylaldehyde 2-Chlorobenzoyl Hydrazone (H2LASSBio-466), Salicylaldehyde 4-Chlorobenzoyl Hydrazone (H2LASSBio-1064) and Their Zinc(II) Complexes</dc:title>
	<dc:date>2011-08-15</dc:date>
	<dc:identifier>doi: 10.3390/molecules16086902</dc:identifier>
		<dc:creator>Walfrido Bispo Júnior</dc:creator>
		<dc:creator>Magna S. Alexandre-Moreira</dc:creator>
		<dc:creator>Marina A. Alves</dc:creator>
		<dc:creator>Anayive Perez-Rebolledo</dc:creator>
		<dc:creator>Gabrieli L. Parrilha</dc:creator>
		<dc:creator>Eduardo E. Castellano</dc:creator>
		<dc:creator>Oscar E. Piro</dc:creator>
		<dc:creator>Eliezer J. Barreiro</dc:creator>
		<dc:creator>Lídia Moreira Lima</dc:creator>
		<dc:creator>Heloisa Beraldo</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/8/6778/">
	<title>Molecules, Vol. 16, Pages 6778-6790: A Biomimetic Chitosan Derivates: Preparation, Characterization and Transdermal Enhancement Studies of N-Arginine Chitosan</title>
	<link>http://www.mdpi.com/1420-3049/16/8/6778/</link>
	<description>A novel arginine-rich chitosan (CS) derivates mimicked cell penetration peptides; N-Arginine chitosan (N-Arg-CS) was prepared by two reaction methods involving activated L-arginine and the amine group on the chitosan. FTIR spectra showed that arginine was chemically coupled with CS. Elemental analysis estimated that the degrees of substitution (DS) of arginine in CS were 6%, 31.3% and 61.5%, respectively. The drug adefovir was chosen as model and its permeation flux across excised mice skin was investigated using a Franz diffusion cell. The results showed that the most effective enhancer was 2% (w/v) concentration of 10 kDa N-Arg-CS with 6% DS. At neutral pH, the cumulative amount of adefovir permeated after 12 hours was 2.63 ± 0.19 mg cm−2 which was 5.83-fold more than adefovir aqueous solution. Meanwhile N-Arg-CS was 1.83, 2.22, and 2.45 times more effective than Azone, eucalyptus and peppermint, respectively. The obtained results suggest that N-Arg-CS could be a promising transdermal enhancer.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/8/6778/</guid>
	<pubDate>Tue, 09 Aug 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-08-09</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>6778</prism:startingPage>
		<prism:endingPage>6790</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>A Biomimetic Chitosan Derivates: Preparation, Characterization and Transdermal Enhancement Studies of N-Arginine Chitosan</dc:title>
	<dc:date>2011-08-09</dc:date>
	<dc:identifier>doi: 10.3390/molecules16086778</dc:identifier>
		<dc:creator>Hui-Xia Lv</dc:creator>
		<dc:creator>Zhen-Hai Zhang</dc:creator>
		<dc:creator>Xiao-Pan Wang</dc:creator>
		<dc:creator>Qing-Qing Cheng</dc:creator>
		<dc:creator>Wei Wang</dc:creator>
		<dc:creator>Xu-Hui Huang</dc:creator>
		<dc:creator>Jian-Ping Zhou</dc:creator>
		<dc:creator>Qiang Zhang</dc:creator>
		<dc:creator>Lu-Lu Hou</dc:creator>
		<dc:creator>Wei Huo</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/8/6322/">
	<title>Molecules, Vol. 16, Pages 6322-6338: Rhinacanthus nasutus Protects Cultured Neuronal Cells against Hypoxia Induced Cell Death</title>
	<link>http://www.mdpi.com/1420-3049/16/8/6322/</link>
	<description>Rhinacanthus nasutus (L.) Kurz (Acanthaceae) is an herb native to Thailand and Southeast Asia, known for its antioxidant properties. Hypoxia leads to an increase in reactive oxygen species in cells and is a leading cause of neuronal damage. Cell death caused by hypoxia has been linked with a number of neurodegenerative diseases including some forms of dementia and stroke, as well as the build up of reactive oxygen species which can lead to diseases such as Huntington’s disease, Parkinson’s disease and Alzeheimer’s disease. In this study we used an airtight culture container and the Mitsubishi Gas Company anaeropack along with the MTT assay, LDH assay and the trypan blue exlusion assay to show that 1 and 10 µg mL−1 root extract of R. nasutus is able to significantly prevent the death of HT-22 cells subjected to hypoxic conditions, and 0.1 to 10 µg mL−1 had no toxic effect on HT-22 under normal conditions, whereas 100 µg mL−1 reduced HT-22 cell proliferation. We also used H2DCFDA staining to show R. nasutus can reduce reactive oxygen species production in HT-22 cells.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/8/6322/</guid>
	<pubDate>Tue, 26 Jul 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-07-26</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>8</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>6322</prism:startingPage>
		<prism:endingPage>6338</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Rhinacanthus nasutus Protects Cultured Neuronal Cells against Hypoxia Induced Cell Death</dc:title>
	<dc:date>2011-07-26</dc:date>
	<dc:identifier>doi: 10.3390/molecules16086322</dc:identifier>
		<dc:creator>James M. Brimson</dc:creator>
		<dc:creator>Tewin Tencomnao</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/7/5840/">
	<title>Molecules, Vol. 16, Pages 5840-5860: Synthesis and Cytotoxic Activity of Some New 2,6-Substituted Purines</title>
	<link>http://www.mdpi.com/1420-3049/16/7/5840/</link>
	<description>A seriesof twenty four acyclic unsaturated 2,6-substututed purines 5a-20b were synthesized. These compounds were evaluated for cytotoxic activity against NCI-60 DTP human tumor cell line screen at 10µMconcentration. N9-[(Z)-4'-chloro-2'-butenyl-1'-yl]-2,6-dichloropurine(5a), N9-[4'-chloro-2'-butynyl-1'-yl]-2,6-dichloropurine(10a), N9-[(E)-2',3'-dibromo-4'-chloro-2'-butenyl-1'-yl]-6-methoxypurine(14)and N9-[4'-chloro-2'-butynyl-1'-yl]-6-(4-methoxyphenyl)-purine(19)exhibited highly potent cytotoxic activity with GI50 values in the 1–5 µM range for most human tumor cell lines. Other compounds exhibited moderate activity.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/7/5840/</guid>
	<pubDate>Mon, 11 Jul 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-07-11</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>5840</prism:startingPage>
		<prism:endingPage>5860</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Synthesis and Cytotoxic Activity of Some New 2,6-Substituted Purines</dc:title>
	<dc:date>2011-07-11</dc:date>
	<dc:identifier>doi: 10.3390/molecules16075840</dc:identifier>
		<dc:creator>Nageswara Rao Kode</dc:creator>
		<dc:creator>Shashikant Phadtare</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/7/5753/">
	<title>Molecules, Vol. 16, Pages 5753: Drozdowska D., New Solid Phase Synthesis of Distamycin Analogues. Molecules, 2011, 16, 3066-3076</title>
	<link>http://www.mdpi.com/1420-3049/16/7/5753/</link>
	<description>The author wishes to make the following correction to this paper [1]:
The correct author’s name is: Danuta Drozdowska.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/7/5753/</guid>
	<pubDate>Wed, 06 Jul 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-07-06</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Correction</prism:section>
	<prism:startingPage>5753</prism:startingPage>
		<prism:endingPage>5753</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Drozdowska D., New Solid Phase Synthesis of Distamycin Analogues. Molecules, 2011, 16, 3066-3076</dc:title>
	<dc:date>2011-07-06</dc:date>
	<dc:identifier>doi: 10.3390/molecules16075753</dc:identifier>
		<dc:creator>Danuta Drozdowska</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/7/5333/">
	<title>Molecules, Vol. 16, Pages 5333-5348: Generation and Detection of Levuglandins and Isolevuglandins In Vitro and In Vivo</title>
	<link>http://www.mdpi.com/1420-3049/16/7/5333/</link>
	<description>Levuglandins (LGs) and isolevuglandins (isoLGs), formed by rearrangement of endoperoxide intermediates generated through the cyclooxygenase and free radical induced oxidation of polyunsaturated fatty acids (PUFAs), are extraordinarily reactive, forming covalent adducts incorporating protein lysyl e-amino groups. Because they accumulate, these adducts provide a dosimeter of oxidative injury. This review provides an updated and comprehensive overview of the generation of LG/isoLG in vitro and in vivo and the detection methods for the adducts of LG/isoLG and biological molecules in vivo.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/7/5333/</guid>
	<pubDate>Fri, 24 Jun 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-06-24</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>5333</prism:startingPage>
		<prism:endingPage>5348</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Generation and Detection of Levuglandins and Isolevuglandins In Vitro and In Vivo</dc:title>
	<dc:date>2011-06-24</dc:date>
	<dc:identifier>doi: 10.3390/molecules16075333</dc:identifier>
		<dc:creator>Ming Zhang</dc:creator>
		<dc:creator>Wei Li</dc:creator>
		<dc:creator>Tao Li</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/6/5194/">
	<title>Molecules, Vol. 16, Pages 5194-5206: Microwave-Assisted Solution-Phase Synthesis and DART-Mass Spectrometric Monitoring of a Combinatorial Library of Indolin-2,3-dione Schiff Bases with Potential Antimycobacterial Activity</title>
	<link>http://www.mdpi.com/1420-3049/16/6/5194/</link>
	<description>A combinatorial library composed of eleven hydrazides A-K and eleven indolin-1,2-dione derivatives 1-11 has been designed to formally generate sublibraries of 22 mixtures, M1-M22 comprising of 121 Schiff bases, A-K(1-11). The designed library has been synthesized by the solution-phase method and microwave-assisted synthetic techniques. The formation of individual compounds of each mixture was confirmed by Direct Analysis in Real Time (DART) as ionization technique connected to an Ion Trap as a mass detector. The synthesized mixtures were evaluated for their antimycobacterial activity against four Mycobacterium strains; M. intercellulari, M. xenopi, M. cheleneoi and M. smegmatis. Variable antimycobacterial activity was revealed with the investigated mixtures and maximum activity was shown by M8, M10, M11, and M15 with MIC values of 1.5, 3.1, 6.2 and 0.09 μg/mL, respectively. Application of the indexed method of analysis on these active mixtures revealed that compounds D8, D10 and D11 may contribute to the activity of the tested mixtures.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/6/5194/</guid>
	<pubDate>Wed, 22 Jun 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-06-22</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>5194</prism:startingPage>
		<prism:endingPage>5206</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Microwave-Assisted Solution-Phase Synthesis and DART-Mass Spectrometric Monitoring of a Combinatorial Library of Indolin-2,3-dione Schiff Bases with Potential Antimycobacterial Activity</dc:title>
	<dc:date>2011-06-22</dc:date>
	<dc:identifier>doi: 10.3390/molecules16065194</dc:identifier>
		<dc:creator>Tarek Aboul-Fadl</dc:creator>
		<dc:creator>Hatem A. Abdel-Aziz</dc:creator>
		<dc:creator>Adnan Kadi</dc:creator>
		<dc:creator>Pervez Ahmad</dc:creator>
		<dc:creator>Tilal Elsaman</dc:creator>
		<dc:creator>Mohamed W. Attwa</dc:creator>
		<dc:creator>Ibrahim A. Darwish</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/6/4897/">
	<title>Molecules, Vol. 16, Pages 4897-4911: Synthesis and In Vitro Protein Tyrosine Kinase Inhibitory Activity of Furan-2-yl(phenyl)methanone Derivatives</title>
	<link>http://www.mdpi.com/1420-3049/16/6/4897/</link>
	<description>A series of novel furan-2-yl(phenyl)methanone derivatives were synthesized, and their structures were established on the basis of 1H-NMR, 13C-NMR and mass spectral data. All the prepared compounds were screened for their in vitro protein tyrosine kinase inhibitory activity and several new derivatives exhibited promising activity, which, in some cases, was identical to, or even better than that of genistein, a positive reference compound. The preliminary structure-activity relationships of these compounds were investigated and are discussed.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/6/4897/</guid>
	<pubDate>Tue, 14 Jun 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-06-14</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>4897</prism:startingPage>
		<prism:endingPage>4911</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Synthesis and In Vitro Protein Tyrosine Kinase Inhibitory Activity of Furan-2-yl(phenyl)methanone Derivatives</dc:title>
	<dc:date>2011-06-14</dc:date>
	<dc:identifier>doi: 10.3390/molecules16064897</dc:identifier>
		<dc:creator>Fei Lang Zheng</dc:creator>
		<dc:creator>Shu Rong Ban</dc:creator>
		<dc:creator>Xiu E Feng</dc:creator>
		<dc:creator>Cheng Xiao Zhao</dc:creator>
		<dc:creator>Wenhan Lin</dc:creator>
		<dc:creator>Qing Shan Li</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/6/4764/">
	<title>Molecules, Vol. 16, Pages 4764-4774: Synthesis and Antimicrobial Activity of Some Novel 5-Alkyl-6-Substituted Uracils and Related Derivatives</title>
	<link>http://www.mdpi.com/1420-3049/16/6/4764/</link>
	<description>6-Chloro-5-ethyl-, n-propyl- and isopropyluracils 5a-c were efficiently prepared from the corresponding 5-alkybarbituric acids 3a-c via treatment with phosphorus oxychloride and N,N-dimethylaniline to yield the corresponding 5-alkyl-2,4,6-trichloro-pyrimidines 4a-c, which were selectively hydrolyzed by heating in 10% aqueous sodium hydroxide for 30 minutes. The reaction of compounds 5a-c with 1-substituted piperazines yielded the corresponding 5-alkyl-6-(4-substituted-1-piperazinyl)uracils 6a-j. The target 8-alkyltetrazolo[1,5-f]pyrimidine-5,7(3H,6H)-diones 7a-c were prepared via the reaction of 5a-c with sodium azide. Compounds 6a-j and 7a-c were tested for in vitro activities against a panel of Gram-positive and Gram-negative bacteria and the yeast-like pathogenic fungus Candida albicans. Compound 6h displayed potent broad-spectrum antibacterial activity, while compound 6b showed moderate activity against the Gram-positive bacteria. All the tested compounds were practically inactive against Candida albicans.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/6/4764/</guid>
	<pubDate>Wed, 08 Jun 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-06-08</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>4764</prism:startingPage>
		<prism:endingPage>4774</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Synthesis and Antimicrobial Activity of Some Novel 5-Alkyl-6-Substituted Uracils and Related Derivatives</dc:title>
	<dc:date>2011-06-08</dc:date>
	<dc:identifier>doi: 10.3390/molecules16064764</dc:identifier>
		<dc:creator>Abdulghafoor A. Al-Turkistani</dc:creator>
		<dc:creator>Omar A. Al-Deeb</dc:creator>
		<dc:creator>Nasser R. El-Brollosy</dc:creator>
		<dc:creator>Ali A. El-Emam</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/6/4660/">
	<title>Molecules, Vol. 16, Pages 4660-4671: Synthesis and Antifungal Evaluation of 1-Aryl-2-dimethyl-aminomethyl-2-propen-1-one Hydrochlorides</title>
	<link>http://www.mdpi.com/1420-3049/16/6/4660/</link>
	<description>The development of resistance to current antifungal therapeutics drives the search for new effective agents. The fact that several acetophenone-derived Mannich bases had shown remarkable antifungal activities in our previous studies led us to design and synthesize some acetophenone-derived Mannich bases, 1-8 and 2-acetylthiophene-derived Mannich base 9, 1-aryl-2-dimethylaminomethyl-2-propen-1-one hydrochloride, to evaluate their antifungal activities. The designed chemical structures have α,β-unsaturated ketone moieties, which are responsible for the bioactivities of the Mannich bases. The aryl part was C6H5 (1); 4-CH3C6H4 (2); 4-CH3OC6H4 (3); 4-ClC6H4 (4); 4-FC6H4 (5); 4-BrC6H4 (6); 4-HOC6H4 (7); 4-NO2C6H4 (8); and C4H3S(2-yl) (9). In this study the designed compounds were synthesized by the conventional heating method and also by the microwave irradiation method to compare these methods in terms of reaction times and yields to find an optimum synthetic method, which can be applied for the synthesis of Mannich bases in further studies. Since there are limited number of studies reporting the synthesis of Mannich bases by microwave irradiation, this study may also contribute to the general literature on Mannich bases. Compound 7 was reported for the first time. Antifungal activities of all compounds and synthesis of the compounds by microwave irradiation were also reported for the first time by this study. Fungi (15 species) were used for antifungal activity test. Amphotericin B was tested as an antifungal reference compound. In conclusion, compounds 1-6, and 9, which had more potent (2–16 times) antifungal activity than the reference compound amphotericin B against some fungi, can be model compounds for further studies to develop new antifungal agents. In addition, microwave irradiation can be considered to reduce reaction period, while the conventional method can still be considered to obtain compounds with higher reaction yields in the synthesis of new Mannich bases.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/6/4660/</guid>
	<pubDate>Fri, 03 Jun 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-06-03</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>4660</prism:startingPage>
		<prism:endingPage>4671</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Synthesis and Antifungal Evaluation of 1-Aryl-2-dimethyl-aminomethyl-2-propen-1-one Hydrochlorides</dc:title>
	<dc:date>2011-06-03</dc:date>
	<dc:identifier>doi: 10.3390/molecules16064660</dc:identifier>
		<dc:creator>Ebru Mete</dc:creator>
		<dc:creator>Halise Inci Gul</dc:creator>
		<dc:creator>Sinan Bilginer</dc:creator>
		<dc:creator>Oztekin Algul</dc:creator>
		<dc:creator>Mehmet Emin Topaloglu</dc:creator>
		<dc:creator>Medine Gulluce</dc:creator>
		<dc:creator>Cavit Kazaz</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/6/4482/">
	<title>Molecules, Vol. 16, Pages 4482-4499: Pharmaceutical Composition of Hydrochlorothiazide:β-Cyclo-dextrin: Preparation by Three Different Methods, Physico-Chemical Characterization and In Vivo Diuretic Activity Evaluation</title>
	<link>http://www.mdpi.com/1420-3049/16/6/4482/</link>
	<description>Hydrochlorothiazide is a common diuretic antihypertensive drug of the thiazide family. Its poor aqueous solubility is one of the reasons for its limited bioavailability after oral administration. This work aimed at the development of a hydrochlorothiazide:β-cyclodextrin (HTZ:β-CD) pharmaceutical composition in order to improve water solubility and bioavailability of the drug. The HTZ:β-CD complexes were prepared by three different methods: spray-drying, freeze-drying and fluid bed. Complexes were characterized by thermal analysis, Fourier transform-infrared (FTIR) spectroscopy, powder X-ray diffractometry, NMR (2D-ROESY), scanning electron microscopy (SEM), particle analysis and intrinsic dissolution. The findings reveal that three binary systems prepared presented better solubility results in comparison with free HTZ. Increased diuretic effect was observed to HTZ:β-CD obtained by fluid bed in comparison to free drug in rats. Results taken together suggest that pharmacological effect of HTZ in complex was increased by solubility improvement promoted by cyclodextrin.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/6/4482/</guid>
	<pubDate>Fri, 27 May 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-05-27</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>4482</prism:startingPage>
		<prism:endingPage>4499</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Pharmaceutical Composition of Hydrochlorothiazide:β-Cyclo-dextrin: Preparation by Three Different Methods, Physico-Chemical Characterization and In Vivo Diuretic Activity Evaluation</dc:title>
	<dc:date>2011-05-27</dc:date>
	<dc:identifier>doi: 10.3390/molecules16064482</dc:identifier>
		<dc:creator>Maria Arlete Silva Pires</dc:creator>
		<dc:creator>Robson Augusto Souza dos Santos</dc:creator>
		<dc:creator>Rubén Dario Sinisterra</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/6/4339/">
	<title>Molecules, Vol. 16, Pages 4339-4347: Synthesis, Characterization, and Antimicrobial Evaluation of Oxadiazole Congeners</title>
	<link>http://www.mdpi.com/1420-3049/16/6/4339/</link>
	<description>A series of 1,3-oxazole, 1,3-thiazole, isomeric 1,2,4-oxadiazole, 1,3,4-oxadiazole, and 1,2,3,4-tetrazole heterocycles was synthesized. All the compounds shared as a common feature the presence of a 4-hydroxyphenyl substituent. The structures of the synthesized compounds were confirmed by MS, 1H-NMR, and elemental analysis. In vitro antimicrobial activity for all the newly synthesized compounds at concentrations of 200-25 μg/mL was evaluated against Gram+ve organisms such as methicillin-resistant Staphylococcus aureus (MRSA), Gram–ve organisms such as Escherichia coli (E. coli), and the fungal strain Aspergillus niger (A. niger) by the cup plate method. Ofloxacin and ketoconazole (10 μg/mL) were used as reference standards for antibacterial and antifungal activity, respectively. Compounds 15, 16, and 20 showed notable antibacterial and antifungal activities at higher concentrations (200 μg/mL), whereas 17-19 were found to display significant antibacterial or antifungal activity (25-50 μg/mL) against the Gram+ve, Gram–ve bacteria, or fungal cells used in the present study.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/6/4339/</guid>
	<pubDate>Wed, 25 May 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-05-25</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>4339</prism:startingPage>
		<prism:endingPage>4347</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Synthesis, Characterization, and Antimicrobial Evaluation of Oxadiazole Congeners</dc:title>
	<dc:date>2011-05-25</dc:date>
	<dc:identifier>doi: 10.3390/molecules16064339</dc:identifier>
		<dc:creator>Bassem Sadek</dc:creator>
		<dc:creator>Khairi Mustafa Salem Fahelelbom</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/5/4140/">
	<title>Molecules, Vol. 16, Pages 4140-4164: Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of Cancer</title>
	<link>http://www.mdpi.com/1420-3049/16/5/4140/</link>
	<description>Aminolevulinic acid (ALA) is an endogenous metabolite normally formed in the mitochondria from succinyl-CoA and glycine. Conjugation of eight ALA molecules yields protoporphyrin IX (PpIX) and finally leads to formation of heme. Conversion of PpIX to its downstream substrates requires the activity of a rate-limiting enzyme ferrochelatase. When ALA is administered externally the abundantly produced PpIX cannot be quickly converted to its final product - heme by ferrochelatase and therefore accumulates within cells. Since PpIX is a potent photosensitizer this metabolic pathway can be exploited in photodynamic therapy (PDT). This is an already approved therapeutic strategy making ALA one of the most successful prodrugs used in cancer treatment.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/5/4140/</guid>
	<pubDate>Thu, 19 May 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-05-19</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>4140</prism:startingPage>
		<prism:endingPage>4164</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of Cancer</dc:title>
	<dc:date>2011-05-19</dc:date>
	<dc:identifier>doi: 10.3390/molecules16054140</dc:identifier>
		<dc:creator>Małgorzata Wachowska</dc:creator>
		<dc:creator>Angelika Muchowicz</dc:creator>
		<dc:creator>Małgorzata Firczuk</dc:creator>
		<dc:creator>Magdalena Gabrysiak</dc:creator>
		<dc:creator>Magdalena Winiarska</dc:creator>
		<dc:creator>Małgorzata Wańczyk</dc:creator>
		<dc:creator>Kamil Bojarczuk</dc:creator>
		<dc:creator>Jakub Golab</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/5/4104/">
	<title>Molecules, Vol. 16, Pages 4104-4121: Solid-Phase Synthesis of Arylpiperazine Derivatives and Implementation of the Distributed Drug Discovery (D3) Project in the Search for CNS Agents</title>
	<link>http://www.mdpi.com/1420-3049/16/5/4104/</link>
	<description>We have successfully implemented the concept of Distributed Drug Discovery (D3) in the search for CNS agents. Herein, we demonstrate, for the first time, student engagement from different sites around the globe in the development of new biologically active compounds. As an outcome we have synthesized a 24-membered library of arylpiperazine derivatives targeted to 5-HT1A and 5-HT2A receptors. The synthesis was simultaneously performed on BAL-MBHA-PS resin in Poland and the United States, and on BAL-PS-SynPhase Lanterns in France. The D3 project strategy opens the possibility of obtaining potent 5-HT1A/5-HT2A agents in a distributed fashion. While the biological testing is still centralized, this combination of distributed synthesis with screening will enable a D3 network of students world-wide to participate, as part of their education, in the synthesis and testing of this class of biologically active compounds.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/5/4104/</guid>
	<pubDate>Thu, 19 May 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-05-19</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>4104</prism:startingPage>
		<prism:endingPage>4121</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Solid-Phase Synthesis of Arylpiperazine Derivatives and Implementation of the Distributed Drug Discovery (D3) Project in the Search for CNS Agents</dc:title>
	<dc:date>2011-05-19</dc:date>
	<dc:identifier>doi: 10.3390/molecules16054104</dc:identifier>
		<dc:creator>Paweł Zajdel</dc:creator>
		<dc:creator>Joanna Król</dc:creator>
		<dc:creator>Katarzyna Grychowska</dc:creator>
		<dc:creator>Maciej Pawłowski</dc:creator>
		<dc:creator>Gilles Subra</dc:creator>
		<dc:creator>Gaël Nomezine</dc:creator>
		<dc:creator>Jean Martinez</dc:creator>
		<dc:creator>Grzegorz Satała</dc:creator>
		<dc:creator>Andrzej J. Bojarski</dc:creator>
		<dc:creator>Ziniu Zhou</dc:creator>
		<dc:creator>Martin J. O’Donnell</dc:creator>
		<dc:creator>William L. Scott</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/5/4020/">
	<title>Molecules, Vol. 16, Pages 4020-4030: Antioxidant and Cytotoxic Constituents from Wisteria sinensis</title>
	<link>http://www.mdpi.com/1420-3049/16/5/4020/</link>
	<description>Chromatographic separation of an aqueous MeOH extract of Wisteria sinensis leaves has yielded six known flavonoids, two triterpene aglycones and the new acylated flavone glycoside chrysoeriol-7-O-[2''-O-(5'''-O-caffeoyl)-β-D-apiofuranosyl]-β-D-glucopyranoside (1). All metabolites were isolated for the first time from the genus Wisteria. Their structures were established on the basis of their chromatographic properties, chemical and physicochemical methods including acid hydrolysis analysis, spectroscopic (UV, 1H- and 13C-NMR) data and confirmed by ESI-MS analysis, as well as two-dimensional NMR (1H-1HCOSY, HMQC and HMBC). Biological studies of the defatted aqueous 80% methanol leaf extract and the major isolates 1, 6 and 7 were undertaken and they are reported herein for the first time to have significant cytotoxic activity against the Hep-G2 tumor cell line in addition to antioxidant activity.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/5/4020/</guid>
	<pubDate>Tue, 17 May 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-05-17</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>4020</prism:startingPage>
		<prism:endingPage>4030</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Antioxidant and Cytotoxic Constituents from Wisteria sinensis</dc:title>
	<dc:date>2011-05-17</dc:date>
	<dc:identifier>doi: 10.3390/molecules16054020</dc:identifier>
		<dc:creator>Mona A. Mohamed</dc:creator>
		<dc:creator>Manal M. Hamed</dc:creator>
		<dc:creator>Allia M. Abdou</dc:creator>
		<dc:creator>Wafaa S. Ahmed</dc:creator>
		<dc:creator>Amal M. Saad</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/16/5/3985/">
	<title>Molecules, Vol. 16, Pages 3985-3998: Synthesis of a Novel Benzoyl Adenosine Analog Containing a 1, 4-Dioxane Sugar Analog and the Synthesis of a Corresponding Uracil Adenine Dinucleotide</title>
	<link>http://www.mdpi.com/1420-3049/16/5/3985/</link>
	<description>Adenosine analogs in which the sugar unit was replaced by a 1,4-dioxane sugar equivalent, were prepared by coupling the 1,4-dioxane sugar analog as its anomeric acetates, with N6-benzoyl protected adenine. The 1,4-dioxane system was obtained in an enantioselective synthesis from (R,R)-dimethyl tartrate. Using standard phosphorimidite methodology, the adenine analog was further reacted with a 1,4-dioxane uridine analog to give the corresponding, protected dinucleotide, set-up for further condensation into larger oligonucleotides.</description>
	
	<guid>http://www.mdpi.com/1420-3049/16/5/3985/</guid>
	<pubDate>Thu, 12 May 2011 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2011-05-12</prism:publicationDate>
	<prism:volume>16</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>3985</prism:startingPage>
		<prism:endingPage>3998</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Synthesis of a Novel Benzoyl Adenosine Analog Containing a 1, 4-Dioxane Sugar Analog and the Synthesis of a Corresponding Uracil Adenine Dinucleotide</dc:title>
	<dc:date>2011-05-12</dc:date>
	<dc:identifier>doi: 10.3390/molecules16053985</dc:identifier>
		<dc:creator>Qiang Yu</dc:creator>
		<dc:creator>Per Carlsen</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>


<cc:License rdf:about="http://creativecommons.org/licenses/by/3.0/">
	<cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
	<cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
	<cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
</cc:License>

</rdf:RDF>
